https://www.pharmaceutical-business-review.com/news/targeted-medical-announces-preliminary-data-of-amino-acid-based-oral-formulation-061212/ 2012-12-06T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/salk-institute-develops-new-technique-for-stem-cell-production-061212/ 2012-12-06T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/cenduit-unveils-new-clinical-trial-forecasting-service-061212/ 2012-12-06T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/max-muscle-launches-new-natural-sleep-aid-supplement-061212/ 2012-12-06T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/pearl-therapeutics-co-suspension-formulation-technology-wins-us-patent-061212/ 2012-12-06T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/uniqure-benitec-enter-into-non-exclusive-cross-licensing-agreement-061212/ 2012-12-06T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-announces-bispecific-antibody-research-deal-with-kyowa-hakko-071212/ 2012-12-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amorfix-cnj-holdings-partner-to-develop-cancer-therapeutics-071212/ 2012-12-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-suspends-licence-of-chemi-pharmaceutical-071212/ 2012-12-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/protalix-signs-deal-with-pfizer-to-advance-gaucher-disease-drug-trials-071212/ 2012-12-07T00:20:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/janssen-seeks-approval-for-stelara-in-us-europe-071212/ 2012-12-07T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmavigilant-unveils-new-drug-accountability-system-071212/ 2012-12-07T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sol-gel-announces-positive-results-from-e-bpo-phase-ii-study-071212/ 2012-12-07T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/sygnis-acquires-x-pol-biotech-071212/ 2012-12-07T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-strides-arcolab-to-supply-cancer-medicines-to-emerging-countries-071212/ 2012-12-07T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/omeros-advances-phase-1-trial-of-oms824-071212/ 2012-12-07T04:09:00+00:00 https://www.pharmaceutical-business-review.com/news/impact-analytical-to-expand-laboratory-071212/ 2012-12-07T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/coti-to-use-chemsas-drug-discovery-system-in-new-drug-research-deal-071212/ 2012-12-07T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/african-global-pharma-wins-approval-for-paracetamol-packaging-insert-071212/ 2012-12-07T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-reports-positive-results-from-phase-ii-myelofibrosis-trial-101212/ 2012-12-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/reparixin-trial-status-to-be-presented-in-sabcs-conference-101212/ 2012-12-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-launches-japanese-encephalitis-vaccine-in-australia-101212/ 2012-12-10T00:36:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-introduces-debiopharm-prostate-cancer-medication-in-india-101212/ 2012-12-10T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/meda-purchases-midnite-otc-sleep-aid-101212/ 2012-12-10T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/leica-galena-to-develop-companion-diagnostic-for-breast-cancer-therapeutic-101212/ 2012-12-10T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/iroko-phase-3-pain-drug-study-meets-primary-endpoint-101212/ 2012-12-10T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/unitaid-funds-to-provide-children-with-access-to-hivaids-malaria-tb-medicines-101212/ 2012-12-10T04:43:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/european-commission-clears-expanded-use-of-genzyme-thyrogen-101212/ 2012-12-10T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/nuron-buys-pfizers-preventive-vaccine-meningitec-101212/ 2012-12-10T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/galena-biopharma-presents-neuvax-phase-12-trials-results-101212/ 2012-12-10T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/basf-unveils-expanded-facility-in-scotland-101212/ 2012-12-10T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/sage-n-research-io-informatics-launch-sentient-ida-111212/ 2012-12-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/probi-viva-5-sign-probiotic-business-deal-for-north-american-markets-111212/ 2012-12-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/perceptive-informatics-inaugurates-new-customer-care-office-in-china-111212/ 2012-12-10T22:36:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-fred-hutchinson-cancer-research-center-sign-research-partnership-111212/ 2012-12-11T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/cet-completes-life-sciences-center-expansion-111212/ 2012-12-11T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/myriad-signs-diabetes-research-collaboration-with-sanofi-phri-111212/ 2012-12-11T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/aequus-biopharma-names-ronald-berenson-as-new-ceo-111212/ 2012-12-11T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/genetex-unveils-histone-h3-phospho-ser10-antibody-111212/ 2012-12-11T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aop-orphan-to-commence-aop2014p1101-phase-iii-trial-111212/ 2012-12-11T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-prostate-cancer-medication-wins-fda-approval-for-expanded-use-111212/ 2012-12-11T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/us-hiv-care-providers-recommend-affordable-prices-for-hiv-drugs-111212/ 2012-12-11T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/frutarom-health-expands-to-latin-america-111212/ 2012-12-11T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-unveils-remaining-strengths-of-reformulated-version-of-opana-er-121212/ 2012-12-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/rising-pharma-launches-generic-grifulvin-tablet-121212/ 2012-12-11T23:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fibrogen-astellas-commence-phase-3-trial-of-anemia-therapeutic-agent-121212/ 2012-12-12T00:22:00+00:00 https://www.pharmaceutical-business-review.com/news/maine-manufacturing-purchases-certain-ge-laboratory-filter-membrane-business-assets-121212/ 2012-12-12T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/suppremol-presents-positive-interim-results-from-sm101-clinical-trial-121212/ 2012-12-12T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/polypid-announces-positive-preliminary-clinical-trial-results-for-bonypid-121212/ 2012-12-12T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/theravance-initiates-td-4208-phase-2b-dose-ranging-study-121212/ 2012-12-12T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-xenon-sign-licensing-deal-for-pain-drug-121212/ 2012-12-12T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-laboratories-almirall-announce-availability-of-anticholinergic-agent-in-us-121212/ 2012-12-12T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/bosch-plans-to-buy-minority-stake-in-industrial-pharmaceutical-resources-121212/ 2012-12-12T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-noa-to-cynapsus-for-atx-101-patent-121212/ 2012-12-12T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-additional-marketing-exclusivity-for-eisais-gerd-drug-121212/ 2012-12-12T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/icig-acquires-pharmaceutical-ingredients-activities-of-tessenderlo-121212/ 2012-12-12T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/infat-found-to-strengthen-infantsbones-in-study-121212/ 2012-12-12T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/immunomedics-develops-bispecific-antibodies-131212/ 2012-12-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cdi-icell-neurons-support-alzheimers-disease-modeling-in-study-131212/ 2012-12-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/duke-university-to-deploy-teramedicas-vendor-neutral-architecture-suite-131212/ 2012-12-12T22:35:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-japan-makes-15m-milestone-payment-to-sucampo-on-amitiza-sale-131212/ 2012-12-13T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-eisai-sign-strategic-manufacturing-deal-at-research-triangle-park-131212/ 2012-12-13T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/moberg-paladin-sign-emtrix-distribution-deal-in-canada-131212/ 2012-12-13T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-the-medicines-join-forces-for-recothrom-131212/ 2012-12-13T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-seeks-fda-approval-for-canagliflozin-metformin-combo-therapy-131212/ 2012-12-13T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-takeda-lundbeck-vortioxetine-nda-filing-for-major-depressive-disorder-131212/ 2012-12-13T04:16:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-to-milos-duchenne-and-becker-muscular-dystrophy-candidate-131212/ 2012-12-13T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/amrap-launches-refuel-nutrition-bar-for-high-intensity-athletes-131212/ 2012-12-13T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/iroko-unveils-new-global-headquarters-in-us-131212/ 2012-12-13T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-lundbeck-collaboration-reaches-third-pre-clinical-milestone-141212/ 2012-12-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bg-medicine-receives-ce-mark-for-cardioscore-test/ 2012-12-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aeterna-zentaris-reports-positive-results-from-phase-2-perifosine-sorafenib-combination-therapy-141212/ 2012-12-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-commences-patient-enrollment-in-mm-141-phase-1-study-141212/ 2012-12-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/xbiotech-reports-positive-data-from-phase-ii-acne-vulgaris-trial-141212/ 2012-12-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-pfizer-ligand-bazedoxifeneconjugated-estrogens-nda-141212/ 2012-12-13T23:20:00+00:00 https://www.pharmaceutical-business-review.com/news/pdc-biotech-completes-phase-i-clinical-trial-of-pdc31-141212/ 2012-12-14T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmavigilant-unveils-new-data-loading-approach-141212/ 2012-12-14T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-flex-m-rheumatoid-arthritis-study-fails-to-meet-efficacy-objectives-141212/ 2012-12-14T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/elite-signs-agreement-for-active-pharmaceutical-ingredient-supply-141212/ 2012-12-14T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/ucl-eisai-join-forces-to-develop-new-therapeutics-for-neurological-diseases-141212/ 2012-12-14T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/umn-pharma-to-produce-biosimilars-cell-lines-using-catalent-gpex-technology-141212/ 2012-12-14T02:39:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-oral-granule-formulation-of-gilead-viread-141212/ 2012-12-14T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-familial-amyloid-polyneuropathy-candidate-wins-fda-fast-track-status-141212/ 2012-12-14T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-novartis-signifor-injection-to-treat-cushings-disease-171212/ 2012-12-16T23:53:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-gsk-raxibacumab-anti-toxin-for-inhalational-anthrax-treatment-171212/ 2012-12-17T00:44:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-handok-to-set-up-new-business-venture-in-south-korea-171212/ 2012-12-17T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/bio-rad-to-take-over-abd-serotec-for-171212/ 2012-12-17T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/gis-fldm-set-up-single-cell-genomics-research-center-in-singapore-171212/ 2012-12-17T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/new-england-biolabs-launches-new-gibson-assembly-cloning-kit-171212/ 2012-12-17T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/cempra-initiates-cem-102-phase-2-trial-in-prosthetic-joint-infection-patients/ 2012-12-17T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/kemira-oyj-sells-pharmaceutical-business-to-niacet-171212/ 2012-12-17T06:26:00+00:00 https://www.pharmaceutical-business-review.com/news/avid-upgrades-manufacturing-facility-171212/ 2012-12-17T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/patheon-acquires-banner-pharmacaps-171212/ 2012-12-17T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/lct-otsuka-join-forces-to-develop-ntcell-for-parkinsons-disease-171212/ 2012-12-17T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-joins-forces-with-mmrf-to-advance-treatment-for-multiple-myeloma-171212/ 2012-12-17T09:00:00+00:00 https://www.pharmaceutical-business-review.com/news/vitamin-shoppe-to-purchase-super-supplements-for-50m-181212/ 2012-12-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/elektas-clarity-4d-monitoring-software-receives-510k-clearance-181212/ 2012-12-17T18:35:00+00:00 https://www.pharmaceutical-business-review.com/news/antares-submits-otrexup-nda-to-fda-181212/ 2012-12-17T18:56:00+00:00 https://www.pharmaceutical-business-review.com/news/phenex-janssen-to-jointly-develop-autoimmune-inflammatory-disorder-therapeutics-181212/ 2012-12-17T23:49:00+00:00 https://www.pharmaceutical-business-review.com/news/recordati-to-buy-non-core-products-of-h-lundbeck-181212/ 2012-12-18T00:08:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-announces-fda-approval-of-seasonal-flu-virus-vaccine-in-us-181212/ 2012-12-18T00:12:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-paladin-silenor-new-drug-submission-181212/ 2012-12-18T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/karus-babraham-institute-collaborate-on-inflammatory-disease-research-181212/ 2012-12-18T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/philip-chapper-bunzl-in-disposable-healthcare-consumables-supply-deal-181212/ 2012-12-18T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/promining-roche-collaborate-on-type-2-diabetes-research-181212/ 2012-12-18T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-evotec-join-forces-to-develop-nmda-antagonist-portfolio-181212/ 2012-12-18T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-clears-abbotts-new-testosterone-test-181212/ 2012-12-18T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/octane-brainstorm-to-develop-bioreactor-for-nurown-stem-cell-production-181212/ 2012-12-18T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/gerresheimer-buys-majority-stake-in-triveni-181212/ 2012-12-18T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mylan-generic-qualaquin-capsules-anda-191212/ 2012-12-19T00:16:00+00:00 https://www.pharmaceutical-business-review.com/news/aurobindo-wins-fda-nod-for-generic-anti-hiv-drug-191212/ 2012-12-19T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/poxel-raises-funds-to-advance-diabetic-drug-development-191212/ 2012-12-19T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/ssb-to-market-umetrics-software-portfolio-globally-191212/ 2012-12-19T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/ironwood-linzess-drug-available-in-us-pharmacies-191212/ 2012-12-19T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/aphios-receives-noa-for-oral-delivery-nanotechnology-patent-191212/ 2012-12-19T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/wuxi-pra-enter-jv-agreement-to-provide-clinical-trial-services-in-china-191212/ 2012-12-19T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmalink-begins-nefecon-phase-iib-study-for-primary-iga-nephropathy-patients-191212/ 2012-12-19T03:58:00+00:00 https://www.pharmaceutical-business-review.com/news/lorus-brock-university-collaborate-to-develop-new-anticancer-drugs-191212/ 2012-12-19T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-to-sell-non-colcrys-url-pharma-to-sun-pharmaceutical-191212/ 2012-12-19T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-theravance-submit-umec-nda-to-fda-191212/ 2012-12-19T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/icap-patent-announces-sale-of-patented-topical-analgesic-cream-191212/ 2012-12-19T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/study-finds-health-benefits-from-infant-formula-fed-with-infat-191212/ 2012-12-19T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/autodesk-to-develop-new-software-for-organovo-3d-bioprinter-201212/ 2012-12-19T23:03:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaneti3-offers-mobile-application-for-bioanalytical-assays-201212/ 2012-12-19T23:22:00+00:00 https://www.pharmaceutical-business-review.com/news/glycovaxyn-gsk-sign-bacterial-vaccine-development-partnership-201212/ 2012-12-20T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/nerre-to-develop-neurokinin-antagonists-separated-from-gsk-201212/ 2012-12-20T00:17:00+00:00 https://www.pharmaceutical-business-review.com/news/amarin-seeks-fda-approval-for-chemport-201212/ 2012-12-20T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/ssb-adds-cell-culture-media-to-its-product-portfolio-201212/ 2012-12-20T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/anima-cell-technology-monitors-protein-production-within-living-cells-during-study-201212/ 2012-12-20T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/stora-enso-chalmers-to-develop-intelligent-pharmaceutical-packaging-201212/ 2012-12-20T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/epigenomics-reports-additional-data-on-epi-procolon-comparison-study-to-fit-201212/ 2012-12-20T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-arrowhead-join-forces-to-develop-peptide-targeted-therapeutics-201212/ 2012-12-20T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amc-health-to-offer-telemonitoring-services-for-lisinopril-trial-201212/ 2012-12-20T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/methylgene-phase-ii-mgcd290-trial-completes-patient-enrollment-201212/ 2012-12-20T07:09:00+00:00 https://www.pharmaceutical-business-review.com/news/humedica-pfizer-collaborate-for-data-driven-research-211212/ 2012-12-20T18:52:00+00:00 https://www.pharmaceutical-business-review.com/news/semantelli-launches-healthcare-focused-big-data-collection-solution-211212/ 2012-12-20T22:42:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-acquires-dendreon-immunotherapy-manufacturing-facility-211212/ 2012-12-21T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/healthcare-royalty-funds-nuron-vaccine-development-programs-211212/ 2012-12-21T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/synthetic-biologics-intrexon-begin-mab-therapy-development-for-whooping-cough-211212/ 2012-12-21T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-department-of-health-approves-antiviral-drugs-for-flu-211212/ 2012-12-21T04:19:00+00:00 https://www.pharmaceutical-business-review.com/news/cempra-initiates-phase-3-study-of-oral-solithromycin-211212/ 2012-12-21T06:41:00+00:00 https://www.pharmaceutical-business-review.com/news/omni-bio-pharma-names-bruce-schneider-as-new-ceo-211212/ 2012-12-21T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-grants-fast-track-status-to-lx1033-241212/ 2012-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aimm-cosmo-pharmaceuticals-join-forces-to-develop-gastrointestinal-therapy-241212/ 2012-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-licenses-immunogen-tap-technology-for-anticancer-therapeutics-development-241212/ 2012-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/synteract-to-acquire-harrison-clinical-research-241212/ 2012-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/finox-submits-r-fsh-biosimilar-maa-to-ema-241212/ 2012-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/rosetta-to-acquire-minority-stake-in-karolinska-241212/ 2012-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/halozyme-pfizer-partner-to-develop-subcutaneous-biologics-241212/ 2012-12-24T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/cevec-yuhan-sign-cap-technology-licensing-deal-241212/ 2012-12-24T04:16:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-patents-atlantic-pharmaceuticals-smartscript-drug-delivery-platform-241212/ 2012-12-24T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/sarepta-join-forces-with-us-niaid-to-develop-influenza-drug-241212/ 2012-12-24T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/blend-therapeutics-appoints-mark-iwicki-as-new-ceo-241212/ 2012-12-24T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/eyegate-enrolls-last-patient-for-egp-437-phase-iii-study-241212/ 2012-12-24T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/allon-therapeutics-davunetide-trial-for-psp-fails-241212/ 2012-12-24T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-use-of-genentech-tamiflu-to-treat-influenza-in-infants-251212/ 2012-12-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ironwood-commences-phase-i-anxiety-drug-trial-in-us-251212/ 2012-12-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-aegerions-juxtapid-capsule-261212/ 2012-12-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-diabetes-therapy-wins-approval-in-japan-261212/ 2012-12-26T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/amag-submits-snda-for-feraheme-injection-to-fda-261212/ 2012-12-26T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-amylin-terminate-anti-obesity-compound-development-deal-261212/ 2012-12-26T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-ucb-rheumatoid-arthritis-therapy-wins-approval-in-japan-261212/ 2012-12-26T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-pfizer-won-approval-for-eliquis-in-japan-271212/ 2012-12-27T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/celator-commences-third-phase-of-leukemia-study-cpx-351-271212/ 2012-12-27T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/opko-health-agrees-to-acquire-silcon-271212/ 2012-12-27T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-and-ajinomoto-receive-approval-for-risedronate-sodium-hydrate-formulation-in-japan-271212/ 2012-12-27T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-aurobindo-pharmas-nafcillin-injections-281212/ 2012-12-27T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-acquires-liquent-281212/ 2012-12-28T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/depomeds-lawsuits-against-watson-laboratories-and-par-pharmaceutical-dismissed-281212/ 2012-12-28T03:56:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-acquires-remaining-shares-of-cobrek-311212/ 2012-12-31T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-grants-anda-for-breckenridges-rizatriptan-benzoate-tablets-311212/ 2012-12-31T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mitsubishi-chemical-to-acquire-qualicaps-311212/ 2012-12-31T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-anda-for-mylans-phenytoin-chewable-tablets-010113/ 2012-12-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mallinckrodt-wins-fda-approval-for-generic-concerta-020113/ 2013-01-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/famy-care-wins-final-fda-approval-for-generic-nordette-28-tablets-020113/ 2013-01-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-wins-fda-approval-for-pulmonary-multi-drug-resistant-tuberculosis-drug-020113/ 2013-01-01T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/proteome-ck1d-inhibitors-improve-cognitive-function-in-in-vivo-alzheimers-disease-study-020113/ 2013-01-02T03:04:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-apeiron-partner-for-cancer-immunotherapy-research-020112/ 2013-01-02T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/softpath-to-introduce-pharmaceutical-business-process-automation-solution-030113/ 2013-01-02T22:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mylan-generic-maxalt-mlt-maxalt-tablet-andas-030113/ 2013-01-02T23:57:00+00:00 https://www.pharmaceutical-business-review.com/news/questcor-agrees-to-acquire-biovectra-030113/ 2013-01-03T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/microbiotix-signs-licensing-deal-with-merck-to-develop-antiviral-candidates-030113/ 2013-01-03T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-pharmaceuticals-introduces-flumazenil-injection-030113/ 2013-01-03T00:44:00+00:00 https://www.pharmaceutical-business-review.com/news/lgc-takes-over-quotient-bioanalytical-sciences-division-030113/ 2013-01-03T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/ibex-takes-over-bio-research-products-030113/ 2013-01-03T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-eliquis-030112/ 2013-01-03T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-watson-anda-for-oxycodone-and-acetaminophen-tablets-030113/ 2013-01-03T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lexmark-takes-over-acuo-technologies-030113/ 2013-01-03T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/tinnitus-control-launches-new-homeopathic-spray-for-tinnitus-030113/ 2013-01-03T03:06:00+00:00 https://www.pharmaceutical-business-review.com/news/astex-begins-sgi-110-phase-2-trial-in-advanced-hepatocellular-carcinoma-patients-030113/ 2013-01-03T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/yuhan-licenses-cevec-cap-technology-030113/ 2013-01-03T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-deploys-cegedim-compliance-solution-suite-040113/ 2013-01-03T23:24:00+00:00 https://www.pharmaceutical-business-review.com/news/ngm-janssen-sign-diabetes-research-partnership-040113/ 2013-01-04T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/innovocommerce-launches-new-innovopoint-clinical-and-investigator-portal-040113/ 2013-01-04T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-introduces-finasteride-tablets-in-us-040113/ 2013-01-04T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-emd-pfizer-multiple-sclerosis-therapy-040113/ 2013-01-04T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/sutro-sanofi-to-jointly-produce-two-vaccine-candidates-040113/ 2013-01-04T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/china-biologic-may-defer-new-production-facility-construction-040113/ 2013-01-04T03:13:00+00:00 https://www.pharmaceutical-business-review.com/news/tongli-to-distribute-dietary-food-supplement-for-human-immunity-040113/ 2013-01-04T04:16:00+00:00 https://www.pharmaceutical-business-review.com/news/maine-manufacturing-buys-ge-healthcare-laboratory-products-040113/ 2013-01-04T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/cerulean-begins-patient-dosing-in-phase-2-study-of-crlx101-040113/ 2013-01-04T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/id3a-to-design-nanoviricides-cgmp-production-and-laboratory-facility-040113/ 2013-01-04T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-onyx-decision-trial-of-nexavar-meets-primary-endpoint-040113/ 2013-01-04T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/vitamin-world-sells-gsc-natural-nasal-spray-in-us-040113/ 2013-01-04T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-obtained-all-shares-in-cell-culture-service-070113/ 2013-01-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/immunovaccine-reports-positive-results-from-depovax-based-anthrax-vaccine-study-070113/ 2013-01-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tranzyme-completes-drug-discovery-partnership-with-bristol-myers-070113/ 2013-01-07T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/optimizerx-samplemd-ecoupon-technology-wins-us-patent-070113/ 2013-01-07T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/glycovaxyn-janssen-enter-multi-valent-bacterial-vaccine-development-deal-070113/ 2013-01-07T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/oxyhives-launches-homeopathic-spray-solution-for-hives-treatment-070113/ 2013-01-07T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmain-lat-pharma-ascite-therapy-wins-fda-orphan-drug-designation-070113/ 2013-01-07T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/vabiotech-licenses-inviragen-technology-for-japanese-encephalitis-vaccine-production-070113/ 2013-01-07T02:02:00+00:00 https://www.pharmaceutical-business-review.com/news/proteon-reports-positive-results-from-prt-201-phase-2-trial-in-chronic-kidney-disease-patients-070113/ 2013-01-07T04:18:00+00:00 https://www.pharmaceutical-business-review.com/news/edison-begins-enrollment-in-phase-2b-friedreichs-ataxia-trial-of-epi-743-070113/ 2013-01-07T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/rhythm-commences-phase-2-trial-of-anti-obesity-drug-070113/ 2013-01-07T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-amplimmune-to-jointly-develop-autoimmune-disease-therapeutic-080113/ 2013-01-07T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/ethris-shire-collaborate-to-develop-rna-based-therapeutics-080113/ 2013-01-08T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-reaches-milestone-under-agreement-with-medimmune-080113/ 2013-01-08T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/japan-tobacco-files-nda-for-ferric-citrate-in-japan-080113/ 2013-01-08T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/adaptimmune-gains-licensing-rights-to-life-tech-antibody-coated-magnetic-beads-080113/ 2013-01-08T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/chattem-buys-otc-antacid-rolaids-from-mcneil-ppc-080113/ 2013-01-08T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-eli-lilly-phase-iii-trials-of-empagliflozin-meet-primary-efficacy-endpoint-080113/ 2013-01-08T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-reassumes-development-of-ly2605541-080113/ 2013-01-08T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/stempar-licenses-quinone-based-compounds-for-cancer-therapeutics-development-080113/ 2013-01-08T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-cangene-varizig-090113/ 2013-01-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/priaxon-gsk-sign-research-collaboration-on-protein-protein-interactions-090113/ 2013-01-08T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/aspireo-reports-positive-preliminary-data-from-somatoprim-phase-ib-study-09013/ 2013-01-08T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/provectus-announces-initiation-of-phase-1-study-of-pv-10-injection-090113/ 2013-01-09T00:08:00+00:00 https://www.pharmaceutical-business-review.com/news/adimab-expands-antibody-research-deals-with-merck-lilly-090113/ 2013-01-09T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-expanded-use-of-pfizer-prevenar-13-vaccine-090113/ 2013-01-09T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/aptuit-aegerion-enter-supply-deal-for-orphan-drug-lomitapide-090113/ 2013-01-09T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-innopharma-anda-for-acetylcysteine-injection-090113/ 2013-01-09T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/newvac-janssen-sign-co-license-agreement-to-develop-quisinostat-090113/ 2013-01-09T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/paladin-signs-pollinex-r-distribution-deal-in-canada-090113/ 2013-01-09T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-dsi-renal-in-omontys-injection-supply-deal-090113/ 2013-01-09T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-introduces-new-cryopreservation-reagents-100113/ 2013-01-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-to-invest-1518m-for-adc-manufacturing-capacity-expansion-100113/ 2013-01-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-yale-university-sign-strategic-research-partnership-100113/ 2013-01-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ilc-dover-takes-over-grayling-industries-100113/ 2013-01-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/santaris-mirage-extend-partnership-on-microrna-therapeutic-research-100113/ 2013-01-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/elsevier-takes-over-france-based-databases-and-information-tools-provider-100113/ 2013-01-09T21:43:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-sanwa-to-launch-hyperkalemia-therapy-in-japan-100113/ 2013-01-09T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-reaches-milestone-in-immuno-inflammation-alliance-with-gsk-100113/ 2013-01-10T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-theravance-submit-regulatory-application-for-copd-therapy-in-europe-100113/ 2013-01-10T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-initiates-temporary-importation-of-sodium-bicarbonate-injection-to-us-100113/ 2013-01-10T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/coda-nexagon-demonstrated-efficacy-in-phase-2b-study-101113/ 2013-01-10T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/morphotek-farletuzumab-phase-iii-study-fails-to-meet-primary-endpoint-110113/ 2013-01-11T00:20:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-wins-eur27m-grant-to-discover-new-antibiotic-therapies-110113/ 2013-01-11T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-divests-abd-serotec-to-bio-rad-110113/ 2013-01-11T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/opko-health-to-take-over-cytochroma-110113/ 2013-01-11T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/reedy-acquisitions-agrees-to-buy-lab21-south-carolina-laboratory-operations-110113/ 2013-01-11T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/hikma-to-buy-egyptian-company-for-pharmaceuticals-chemical-industries-110113_3774411-3774411/ 2013-01-11T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/sorrento-to-apply-antibody-library-technology-for-rivig-production-110113/ 2013-01-11T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/geovax-completes-patient-enrollment-in-phase-12-trial-of-hivaids-therapeutic-vaccine-110113/ 2013-01-11T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/biotest-adma-sign-manufacturing-deal-140113/ 2013-01-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/telik-announces-fda-orphan-drug-designation-of-ezatiostat-hcl-140113/ 2013-01-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/celerion-expands-respiratory-capabilities-with-on-site-bronchoscopy-suite140113/ 2013-01-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-reaches-milestone-in-drug-discovery-alliance-with-ono-pharmaceutical-140113/ 2013-01-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/inergetics-takes-over-bikini-ready-slimtrim-brands-140113/ 2013-01-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nutricia-introduces-otc-product-for-dietary-management-of-alzheimers-disease-140113/ 2013-01-14T04:19:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-cilag-wins-extended-license-to-zytiga-in-europe-140113/ 2013-01-14T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-arqule-report-top-line-results-from-phase-2-study-of-tivantinib140113/ 2013-01-14T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-noa-to-amarin-vascepa-capsules-140113/ 2013-01-14T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmathene-to-use-perc6-technology-in-recombinant-bioscavenger-production-150113/ 2013-01-15T00:07:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-introduces-attention-deficit-hyperactivity-disorder-therapy-in-us-150113/ 2013-01-15T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-establishes-new-formulation-development-facility/ 2013-01-15T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/novalix-kyowa-sign-fragment-based-drug-discovery-alliance-150113/ 2013-01-15T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/santarus-wins-fda-approval-for-ulcerative-colitis-therapy-150113/ 2013-01-15T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/solixir-introduces-functional-drink-to-enhance-mental-clarity-150113/ 2013-01-15T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/genetex-to-introduce-new-easyblot-secondary-antibody-150113/ 2013-01-15T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/royal-dsm-signs-xd-technology-licensing-deal-with-amgen-150113/ 2013-01-15T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/vitapath-opens-new-vitamin-and-supplement-retail-stores-in-canada-150113/ 2013-01-15T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/basf-increases-cash-offer-to-nok1350-per-share-for-pronova-biopharma-160113/ 2013-01-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/springhill-medical-chooses-omnicell-medication-automation-solutions-180113/ 2013-01-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-eli-lilly-avid-amyvid-diagnostic-radiopharmaceutical-160113/ 2013-01-15T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/puramed-lipigesic-m-wins-patent-allowance-in-us-160113/ 2013-01-16T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/ge-healthcare-seeks-permission-for-self-manufacturing-of-optison-150113/ 2013-01-16T00:38:00+00:00 https://www.pharmaceutical-business-review.com/news/regal-supplements-unveils-new-natural-detox-supplement-160113/ 2013-01-16T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/ats-labs-takes-over-microbial-identification-testing-services-provider-160113/ 2013-01-16T02:03:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-buys-structure-based-drug-discovery-company-160113/ 2013-01-16T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/dbv-inra-win-research-grant-to-develop-pediatric-respiratory-syncytial-virus-vaccine-160113/ 2013-01-16T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/uluru-unveils-altrazeal-075gm-blister-pack-in-us-160113/ 2013-01-16T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/genoa-mcmaster-university-in-inhaled-gp-101-research-deal-160113/ 2013-01-16T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/velocity-pharmaceutical-eumederis-sign-clinical-development-deal-160113/ 2013-01-16T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-launches-visiontracker-for-lab-samples-180113/ 2013-01-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nanosmart-ucla-partner-to-advance-development-of-drug-delivery-platform-170113/ 2013-01-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-to-invest-200m-in-new-singapore-manufacturing-facility-170113/ 2013-01-16T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/venaxis-commences-appy1-pivotal-study-in-us-170113/ 2013-01-16T23:46:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-reaches-milestone-in-research-collaboration-with-janssen-170113/ 2013-01-16T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/170113fda-accepts-astellas-supplemental-new-drug-application-for-tarceva/ 2013-01-17T00:17:00+00:00 https://www.pharmaceutical-business-review.com/news/duchesnay-tzamal-sign-diclectin-distribution-deal-in-israel-170113/ 2013-01-17T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/monosol-signs-zuplenz-licensing-deal-with-vestiq-170113/ 2013-01-17T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-elan-seek-fda-ema-approvals-for-first-line-tysabri-use-in-ms-170113/ 2013-01-17T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-ranbaxy-to-combine-thailand-business-operations-170113/ 2013-01-17T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-forest-laboratories-hypertension-therapy-180113/ 2013-01-17T23:39:00+00:00 https://www.pharmaceutical-business-review.com/news/lgc-expands-nucleic-acid-extraction-service-capacity-in-north-america-180113/ 2013-01-17T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/sts-health-introduces-new-otc-formulation-against-cold-flu-like-symptoms-180113/ 2013-01-17T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/mevesi-announces-new-partnership-with-mevesi-180113/ 2013-01-18T00:10:00+00:00 https://www.pharmaceutical-business-review.com/news/nextrials-to-showcase-prism-clinical-trial-management-solution-180113/ 2013-01-18T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-uses-xencor-xtend-half-life-extension-technology-in-therapeutic-antibody-180113/ 2013-01-18T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/paladin-wins-commercialization-rights-to-apeiron-apn311-in-canada-sub-saharan-africa-180113/ 2013-01-18T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/teijin-pharma-to-launch-ipsen-somatuline-in-japan-180113/ 2013-01-18T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/lifelabs-to-take-over-bc-biomedical-laboratories-180113/ 2013-01-18T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-signs-deal-to-evaluate-barofold-preemt-high-pressure-refolding-technology-180113/ 2013-01-18T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/karyopharm-begins-patient-dosing-in-phase-1-acute-myeloid-leukemia-trial-of-kpt-330-210113/ 2013-01-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-bosutinib-wins-positive-chmp-opinion-for-conditional-marketing-authorization-in-europe-210113/ 2013-01-20T23:16:00+00:00 https://www.pharmaceutical-business-review.com/news/essential-edibles-unveils-new-natural-energy-supplement-210113/ 2013-01-20T23:20:00+00:00 https://www.pharmaceutical-business-review.com/news/augmenta-vaccine-technology-wins-us-patent-210113/ 2013-01-21T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/block-engineering-pfizer-to-jointly-develop-cleaning-verification-technology-210113/ 2013-01-21T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/paxvax-installs-g-con-pod-technology-at-san-diego-vaccine-production-facility-210113/ 2013-01-21T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/axelar-initiates-phase-iii-brain-tumour-study-of-axl1717-in-us-210113/ 2013-01-21T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-allergan-overactive-bladder-therapy-210113/ 2013-01-21T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/glycomimetics-completes-enrollment-in-phase-2-study-of-gmi-1070-210113/ 2013-01-21T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/creagri-connell-brothers-sign-hidrox-distribution-agreement-220113/ 2013-01-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-adopts-positive-opinion-for-novartis-acute-gouty-arthritis-therapy-220113/ 2013-01-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-gets-clearance-to-market-tresiba-ryzodeg-diabetes-drugs-in-europe-220113/ 2013-01-22T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/intermune-introduces-idiopathic-pulmonary-fibrosis-therapy-in-canada-210113/ 2013-01-22T00:16:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-behring-begins-pediatric-phase-iii-hemophilia-b-study-of-rix-fp-220113/ 2013-01-22T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/six-translational-health-research-centers-partner-to-advance-drug-development-220113/ 2013-01-22T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/amunix-janssen-biotech-sign-xten-technology-licensing-contract-220113/ 2013-01-22T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/kiadis-pharma-atir-wins-us-patent-protection-220113/ 2013-01-22T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/pct-to-provide-development-manufacturing-services-to-adaptimmune-220113/ 2013-01-22T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/chromadex-signs-distribution-deal-with-isolife-230113/ 2013-01-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-lupin-combined-oral-contraceptive-medication-230113/ 2013-01-23T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/lorus-therapeutics-il-17e-cancer-therapy-wins-us-patent-230113/ 2013-01-23T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/parent-project-muscular-dystrophy-funds-duchenne-muscular-dystrophy-study-230113/ 2013-01-23T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/stellar-biotechnologies-develops-aquaculture-system-for-klh-manufacturing-230113/ 2013-01-23T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/synthon-opens-new-gmp-antibody-drug-conjugate-production-facility-in-nijmegen-230113/ 2013-01-23T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/dezima-signs-licensing-deal-with-mitsubishi-tanabe-for-dez-001-230113/ 2013-01-23T03:22:00+00:00 https://www.pharmaceutical-business-review.com/news/tvm-life-science-announces-first-investment-in-kaneq-bioscience-230113/ 2013-01-23T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/xceleron-forms-strategic-alliance-with-crystal-pharmatech-230113/ 2013-01-23T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mallinckrodt-gablofen-prefilled-syringes-230113/ 2013-01-23T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/prozess-technologie-join-forces-with-applied-group-250113/ 2013-01-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-second-phase-iii-depression-study-of-armodafinil-fails-to-meet-endpoints-240113/ 2013-01-24T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/nymox-reports-positive-results-from-phase-3-benign-prostatic-hyperplasia-study-of-nx-1207-240113/ 2013-01-24T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/generex-submits-oral-insulin-phase-iii-trial-dossier-to-indian-government-240113/ 2013-01-24T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/oncocard-selects-verumde-as-contract-research-organization-240113/ 2013-01-24T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/life-tech-takes-over-netherlands-based-protein-purification-products-developer-240113/ 2013-01-24T02:02:00+00:00 https://www.pharmaceutical-business-review.com/news/biodelivery-sciences-completes-safety-trial-of-bnx-for-opioid-dependence-treatment-240113/ 2013-01-24T03:01:00+00:00 https://www.pharmaceutical-business-review.com/news/perkinelmer-introduces-janus-biotx-pro-automated-workstation-240113/ 2013-01-24T03:13:00+00:00 https://www.pharmaceutical-business-review.com/news/african-mango-plus-introduces-new-weight-loss-supplement-240113/ 2013-01-24T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/chemaxon-deposits-crowd-sourced-chemical-structures-to-pubchem-repository-250113/ 2013-01-24T22:20:00+00:00 https://www.pharmaceutical-business-review.com/news/moulder-centre-selects-dotmatics-informatics-technology-250113/ 2013-01-24T22:43:00+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-makes-cometriq-available-in-us-250113/ 2013-01-24T23:30:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-announces-labeling-update-for-statins-250113/ 2013-01-25T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-phase-4-major-depressive-disorder-study-of-pristiq-meets-primary-endpoint-250113/ 2013-01-25T00:16:00+00:00 https://www.pharmaceutical-business-review.com/news/fisher-to-distribute-response-infectious-disease-tests-in-us-250113/ 2013-01-25T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/epic-sciences-wins-phase-ii-sbir-contract-to-advance-lung-cancer-assay-250113/ 2013-01-25T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/auxogyn-early-embryo-viability-assessment-test-expands-in-europe-250113/ 2013-01-25T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/ibm-announces-new-antimicrobial-hydrogel-250113/ 2013-01-25T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-signs-knowledge-transfer-partnership-with-queens-university-250113/ 2013-01-25T03:39:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-begins-tenofovir-alafenamide-phase-3-hiv-study-250113/ 2013-01-25T03:47:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-commences-th-302-phase-3-study-in-pancreatic-adenocarcinoma-patients-280113/ 2013-01-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-phase-3-pegfilgrastim-and-anti-vegf-evaluation-study-meets-primary-endpoint-280113/ 2013-01-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-varian-brachytherapy-treatment-planning-solution-280113/ 2013-01-27T22:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-expanded-use-of-pfizer-pneumococcal-conjugate-vaccine-prevnar-13-280113/ 2013-01-28T00:10:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-three-new-takeda-type-2-diabetes-therapies-280113/ 2013-01-28T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-introduces-desloratadine-odt-in-us-280113/ 2013-01-28T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/european-patent-protects-sirona-biochem-carbohydrate-chemistry-platform-280113/ 2013-01-28T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-wins-fda-approval-for-overactive-bladder-otc-treatment-in-women-280113/ 2013-01-28T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/ge-healthcare-launches-new-emr-and-practice-management-solution-280113/ 2013-01-28T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/sartorius-wins-leed-platinum-certification-for-manufacturing-facility-in-puerto-rico-280113/ 2013-01-28T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/medicago-mitsubishi-partner-to-develop-closed-plant-production-system-290113/ 2013-01-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/molecularmd-obtains-patent-rights-to-cancer-diagnosis-technology-290113/ 2013-01-28T19:12:00+00:00 https://www.pharmaceutical-business-review.com/news/gvk-biosciences-endo-pharmaceuticals-sign-research-collaboration-290113/ 2013-01-28T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/elite-commences-product-shipment-from-expanded-facility-290113/ 2013-01-29T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-genzyme-lemtrada-biologics-license-application-for-review-290113/ 2013-01-29T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/aoxing-wins-sfda-production-license-for-pholcodine-290113/ 2013-01-29T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/champion-invigorate-sports-drink-now-contains-sustamine-ingredient-290113/ 2013-01-29T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/algeta-oncology-research-program-to-evaluate-targeted-thorium-conjugate-290113/ 2013-01-29T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/idenix-janssen-to-jointly-develop-hcv-combination-therapies-290113/ 2013-01-29T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-to-acquire-investigational-hemophilia-compound-and-related-assets-290113/ 2013-01-29T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-to-manufacture-autologous-virally-transfected-t-cell-product-300113/ 2013-01-29T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/tigenix-renews-gmp-license-for-madrid-manufacturing-facility-300113/ 2013-01-30T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-genzyme-isis-homozygous-familial-hypercholesterolemia-therapy-300113/ 2013-01-30T00:38:00+00:00 https://www.pharmaceutical-business-review.com/news/amorfix-qps-partner-on-alzheimers-disease-diagnostic-ep-ad-assay-project-300113/ 2013-01-30T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/diamedica-completes-cgmp-manufacturing-glp-toxicology-studies-of-dm-199-compound-300113/ 2013-01-30T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-signs-deal-to-develop-afraxis-proprietary-compounds-300113/ 2013-01-30T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/scinopharm-foresee-to-form-jv-to-develop-oncological-peptide-drugs-300113/ 2013-01-30T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-reports-decline-in-q4-net-income-300113/ 2013-01-30T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/noven-announces-us-launch-of-estradiol-transdermal-system-300113/ 2013-01-30T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/cumberland-pt-soho-sign-caldolor-licensing-deal-in-indonesia-300113/ 2013-01-30T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/oxford-lophius-sign-licensing-deals-for-t-cell-based-assay-developments-310113/ 2013-01-30T23:19:00+00:00 https://www.pharmaceutical-business-review.com/news/sciclone-renews-product-promotion-agreement-with-sanofi-in-china-310113/ 2013-01-30T23:21:00+00:00 https://www.pharmaceutical-business-review.com/news/helsinn-signs-anamorelin-distribution-licensing-deal-with-stendhal-310113/ 2013-01-31T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/psi-cro-announces-expansion-of-clinical-data-management-services-310113/ 2013-01-31T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-orbeshield-wins-fda-fast-track-designation-310013/ 2013-01-31T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-announces-us-launch-of-voice-guided-epinephrine-auto-injector-310113/ 2013-01-31T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/blue-shield-of-california-selects-outcomesmtm-for-medication-therapy-management-services-310113/ 2013-01-31T00:54:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-terminates-partnership-with-curetech-311013/ 2013-01-31T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/dataapex-launches-new-control-driver-for-cetac-asx-8000-autosampler-010213/ 2013-01-31T20:30:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-notice-of-issuance-to-targeted-medical-comprehensive-billing-patent-010213/ 2013-01-31T23:30:00+00:00 https://www.pharmaceutical-business-review.com/news/magforce-partners-with-university-of-bremen-to-develop-magnetic-iron-oxide-particles-010213/ 2013-02-01T00:37:00+00:00 https://www.pharmaceutical-business-review.com/news/clondalkin-promotes-david-lennon-to-global-ceo-for-pharma-healthcare-operations-010213/ 2013-02-01T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/nice-issues-preliminary-decision-on-forxiga-medicine-010213/ 2013-02-01T01:55:00+00:00 https://www.pharmaceutical-business-review.com/news/systech-ssps-to-address-scalability-concerns-in-pharmaceutical-serialization-market-010213/ 2013-02-01T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/elan-to-sell-remaining-ordinary-shares-of-alkermes-010213/ 2013-02-01T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/basf-takes-over-pronova-biopharma-010213/ 2013-02-01T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/allenex-eurostam-recieve-26m-grant-from-ec-010213/ 2013-02-01T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-moves-into-new-gmp-facility-for-placental-expanded-cell-production-040213/ 2013-02-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hokutou-holdings-to-establish-new-supplement-and-nutraceuticals-company-040213/ 2013-02-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/appature-dki-collaborate-to-deliver-insight-based-strategic-rm-outcomes-040213/ 2013-02-03T23:07:00+00:00 https://www.pharmaceutical-business-review.com/news/supernus-launches-oxtellar-xr-antiepileptic-drug-in-us-040213/ 2013-02-04T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/mdh-radiology-teams-up-with-sectra-to-provide-telemammography-solution-in-us-040213/ 2013-02-04T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/covidien-files-form-10-registration-statement-with-sec-040213/ 2013-02-04T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cerulean-doses-first-patient-in-phase-2-study-of-crlx101-drug-040213/ 2013-02-04T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-hyperion-therapeutics-ravicti-drug-for-treating-ucd-040213/ 2013-02-04T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/us-federal-judge-issues-permanent-consent-decree-to-ben-venue-laboratories-040213/ 2013-02-04T06:44:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-to-market-adcetris-in-canada-040213/ 2013-02-04T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-biomarker-qualification-group-extends-license-of-gvk-gobiom-database-050213/ 2013-02-04T19:10:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-fission-neutrino-hepatitis-c-studies-meet-primary-endpoints-050213/ 2013-02-05T00:44:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmasyntez-to-market-oasmia-cancer-drug-in-russia-cis-countries-050213/ 2013-02-05T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/raqualia-pharma-interprotein-sign-drug-discovery-research-deal-for-ppi-inhibitors-050213/ 2013-02-05T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/sweden-medical-products-agency-grants-gmp-certificate-for-bend-research-050213/ 2013-02-05T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-initiates-ind-enabling-studies-of-anti-ox40-monoclonal-antibody-050213/ 2013-02-05T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/gamida-meets-primary-endpoint-in-phase-iiiii-study-of-stemex-050213/ 2013-02-05T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-to-commence-phase-2-studies-of-gsk2586184-jak1-molecule-060213/ 2013-02-06T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-pharma-logistics-recalls-certain-over-the-counter-products-in-barbados-060113/ 2013-02-06T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/portola-collaborates-with-bayer-janssen-for-phase-2-study-of-prt4445-060113/ 2013-02-06T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/apceth-receives-second-round-of-funding-for-cancer-therapeutic-development-050213/ 2013-02-06T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/aspen-plans-to-take-over-merck-active-pharmaceutical-ingredient-manufacturing-plant-060213/ 2013-02-06T01:16:00+00:00 https://www.pharmaceutical-business-review.com/news/bond-laboratories-announces-launch-of-new-weight-loss-supplement-060213/ 2013-02-06T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-renews-alliance-partnership-with-jacobs-060213/ 2013-02-06T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/kala-wins-grant-to-extend-research-of-mucusal-penetrating-product-platform-060213/ 2013-02-06T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/uniqure-makes-milestone-payment-to-xenon-for-european-approval-of-glybera-060213/ 2013-02-06T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-sun-pharma-anda-for-generic-doxil-060213/ 2013-02-06T06:55:00+00:00 https://www.pharmaceutical-business-review.com/news/phylogica-collaborates-with-bio-link-to-commercialize-anti-inflammatory-phylomer-peptides-060213/ 2013-02-06T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-almac-pennsylvania-packaging-facility-070213/ 2013-02-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-san-diego-facility-expands-for-additional-life-science-research-070213/ 2013-02-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/vestiq-bmg-pharma-sign-gelx-oral-gel-distribution-deal-070213/ 2013-02-07T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/nusil-launches-med-5440-fluorosilicone-elastomer-070213/ 2013-02-07T00:36:00+00:00 https://www.pharmaceutical-business-review.com/news/rexam-to-expand-la-verpillire-production-site-in-france-070213/ 2013-02-07T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-elite-supplemental-application-for-naltrexone-tablets-070213/ 2013-02-07T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/navidea-maimonides-medical-center-collaborate-on-lymphoseek-injection-utility-research-070213/ 2013-02-07T03:06:00+00:00 https://www.pharmaceutical-business-review.com/news/rockwell-announces-positive-results-from-prime-study-of-iron-delivery-drug-070213/ 2013-02-07T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-announces-issuance-of-additional-us-patent-notice-of-allowance-to-rayos-070213/ 2013-02-07T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-warner-delzicol-ulcerative-colitis-therapy-070213/ 2013-02-07T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/oxigene-confirms-tolerability-in-second-toxicity-analysis-of-ovarian-cancer-drug-trial-070213/ 2013-02-07T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/dna-link-affymetrix-join-forces-for-forensic-test-development-070213/ 2013-02-07T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-chooses-veeva-customer-relationship-management-irep-solutions-080213/ 2013-02-07T23:29:00+00:00 https://www.pharmaceutical-business-review.com/news/apogenix-myelodysplastic-syndrome-therapy-wins-fda-orphan-drug-designation-080213/ 2013-02-08T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/ansell-announces-commencement-of-operations-at-sri-lankan-rd-centre-080213/ 2013-02-08T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-submits-marketing-authorisation-application-for-metastatic-melanoma-therapy-080213/ 2013-02-08T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/meadwestvaco-to-invest-in-german-pharmaceutical-manufacturing-centre-of-excellence-080213/ 2013-02-08T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-wins-new-us-patent-for-antibody-platform-ylanthia-080213/ 2013-02-08T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/organic-india-launches-single-ingredient-moringa-products-in-us-080213/ 2013-02-08T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/albemarle-fine-chemistry-services-to-add-new-capacity-to-pennsylvania-site-080213/ 2013-02-08T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/mystic-obtains-us-patent-for-intranasal-cartridge-devices-080213/ 2013-02-08T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/true-diagnostics-obtains-ce-mark-for-quantitative-prostate-specific-hormone-test-080213/ 2013-02-08T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/pomalyst-advanced-multiple-myeloma-therapy-wins-fda-approval-110213/ 2013-02-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/argenta-teams-up-with-antabio-to-identify-new-antibacterial-agents-110213/ 2013-02-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-reyataz-labeling-change-110213/ 2013-02-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ibm-wellpoint-memorial-sloan-kettering-unveil-new-cognitive-computing-technologies-110213/ 2013-02-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/huron-valley-physicians-association-to-deploy-e-mds-solution-series-110213/ 2013-02-10T21:45:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-jubilant-hollisterstier-site-for-definity-production-110213/ 2013-02-11T00:07:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-sobi-report-positive-data-from-recombinant-fc-fusion-proteins-studies-110213/ 2013-02-11T00:17:00+00:00 https://www.pharmaceutical-business-review.com/news/biotage-launches-updated-version-of-its-isolera-spektra-software-110213/ 2013-02-11T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/concert-reaches-milestone-under-avanir-deal-110213/ 2013-02-11T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/pergamum-cadila-partner-to-develop-new-therapeutic-peptide-targeting-infections-110213/ 2013-02-11T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/university-of-leeds-deploys-dotmatics-vortex-scientific-intelligence-tool-110213/ 2013-02-11T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/schott-kaisha-opens-new-automated-pharma-packaging-plant-in-india-110213/ 2013-02-11T03:37:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-takes-over-ym-biosciences-110213/ 2013-02-11T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/creagri-newwave-sign-distribution-deal-for-olivenol-110213/ 2013-02-11T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/julphar-inaugurates-manufacturing-facility-in-ethiopia-110213/ 2013-02-11T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/innovus-to-buy-us-prescription-drugs-from-prospector-capital-120213/ 2013-02-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/critical-concludes-on-cp024-intranasal-growth-hormone-trial-120213/ 2013-02-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-ucla-ind-application-to-commence-embryonic-stem-cell-based-trial-110213/ 2013-02-11T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/amri-chai-sign-licensing-deal-to-develop-tubulin-inhibitor-compound-120213/ 2013-02-12T00:37:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-commences-commercial-launch-of-rayos-delayed-release-tablets-120213/ 2013-02-12T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/sanford-burnham-florida-hospital-extend-obesity-research-partnership-with-takeda-120213/ 2013-02-12T01:16:00+00:00 https://www.pharmaceutical-business-review.com/news/daibochi-to-establish-new-manufacturing-plant-in-malaysia-120213/ 2013-02-12T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/hokutou-holdings-to-unveil-energy-boosting-supplements-120213/ 2013-02-12T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/cbpe-sells-rosemont-pharmaceuticals-to-perrigo-120213/ 2013-02-12T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/geo-vision-unveils-new-weight-loss-supplement-120213/ 2013-02-12T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/qualitas-valicor-partner-to-commercialize-algae-based-omega-3-supplements-120213/ 2013-02-12T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/agilent-ameritox-sign-research-deal-to-advance-medication-monitoring-120213/ 2013-02-12T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/sobi-pharmaswiss-sign-new-distribution-agreement-130213/ 2013-02-12T19:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lycera-merck-partner-to-develop-autoimmune-disease-therapeutics-130213/ 2013-02-12T23:39:00+00:00 https://www.pharmaceutical-business-review.com/news/rqx-pharmaceuticals-signs-drug-discovery-deal-with-genentech-130213/ 2013-02-12T23:46:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-reaches-milestone-under-discovery-deal-with-ono-130213/ 2013-02-13T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-agrees-to-use-mesoblast-singapore-manufacturing-facility-for-mpcs-production-130213/ 2013-02-13T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/mphase-technologies-submits-us-patent-application-for-drug-delivery-system-130213/ 2013-02-13T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-noa-for-collegium-opioid-product-patent-application-130213/ 2013-02-13T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/cellmid-signs-option-to-license-agreement-for-diagnostic-technology-130213/ 2013-02-13T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/acelrx-names-adrian-adams-as-board-chairman-130213/ 2013-02-13T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-to-deploy-chemaxon-chemistry-software-platform-140213/ 2013-02-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/kl-chooses-openclinica-enterprise-clinical-trial-software-140213/ 2013-02-13T23:07:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-biocon-collaborate-on-development-marketing-of-generic-insulin-analog-products/ 2013-02-13T23:34:00+00:00 https://www.pharmaceutical-business-review.com/news/amri-codexis-sign-smartsourcing-partnership-140213/ 2013-02-14T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/osaka-prefectural-government-issues-order-for-corrective-action-to-takeda-140213/ 2013-02-14T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/prolor-biotech-hgh-ctp-wins-european-orphan-drug-designation-140213/ 2013-02-14T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/able-star-unveils-new-remique-dietary-supplement-140213/ 2013-02-14T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/covaris-enters-into-marketing-strategic-alliance-with-horiba-140213/ 2013-02-14T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/dako-pfizer-teams-up-for-companion-diagnostics-140213/ 2013-02-14T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/styron-unveils-new-resins-for-medical-equipment-housings-140213/ 2013-02-14T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/adaptimmune-chooses-scian-edcpro-solution-150213/ 2013-02-14T22:59:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-teva-generic-attention-deficit-hyperactivity-disorder-therapy-150213/ 2013-02-14T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/santarus-launches-new-ulcerative-colitis-therapy-150213/ 2013-02-15T00:17:00+00:00 https://www.pharmaceutical-business-review.com/news/aurobindo-pharma-wins-fda-marketing-approval-for-diabetes-drugs-150213/ 2013-02-15T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-signs-over-the-counter-distribution-deal-with-reckitt-benckiser-150213/ 2013-02-15T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/cambrex-dow-chemical-partner-for-drug-solubility-solution-150213/ 2013-02-15T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/hokutou-holdings-develops-new-male-enhancement-supplement-150213/ 2013-02-15T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/oragenics-intrexon-collaboration-expands-lantibiotic-mu1140-production-150213/ 2013-02-15T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/coyote-commences-gmp-manufacturing-process-for-cns-102-150213/ 2013-02-15T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-to-launch-new-diabetes-therapy-in-japan-150213/ 2013-02-15T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/atlab-atl101-demonstrates-favourable-results-in-phase-ii-study-180213/ 2013-02-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-heptares-to-jointly-develop-antibody-therapeutics-against-gpcrs-180213/ 2013-02-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dako-launches-iqish-technology-to-decrease-cancer-evaluation-turnaround-time-180213/ 2013-02-17T20:27:00+00:00 https://www.pharmaceutical-business-review.com/news/northwise-services-to-deploy-merge-eclinical-os-solution-180213/ 2013-02-17T22:28:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-zortress-mediaction-wins-fda-nod-to-prevent-liver-transplantation-rejection-180213/ 2013-02-18T00:10:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-voluntarily-recalls-one-lot-of-vistide-180213/ 2013-02-18T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/opko-health-takes-over-silcon-180213/ 2013-02-18T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/viiv-hiv-infection-therapy-wins-fda-priority-review-status-180213/ 2013-02-18T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/quality-chemicals-to-produce-new-oral-antiretroviral-drug-180213/ 2013-02-18T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/neurim-reports-positive-piromelatine-phase-ii-study-data/ 2013-02-18T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/u3-pharma-abcheck-in-antibody-discovery-research-collaboration-180213/ 2013-02-18T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fortebio-launches-new-dip-and-read-ni-nta-biosensor-180213/ 2013-02-18T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/reumofan-voluntarily-recalls-all-lots-of-reumofan-plus-tablets-180213/ 2013-02-18T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/cryoxtract-wins-noa-for-frozen-sample-aliquotting-technology-patent-application-150213/ 2013-02-18T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/precision-wins-us-patent-for-genetically-modified-cell-production-methods-190213/ 2013-02-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-chiasma-to-jointly-develop-investigational-octreolin-190213/ 2013-02-18T23:53:00+00:00 https://www.pharmaceutical-business-review.com/news/edison-commences-epi-743-phase-2-study-in-cobalamin-c-deficient-patients-190213/ 2013-02-19T00:36:00+00:00 https://www.pharmaceutical-business-review.com/news/uc-san-diego-moores-cancer-center-joins-win-consortium-190213/ 2013-02-19T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/epistem-contract-research-division-ihc-laboratories-wins-gclp-status-190213/ 2013-02-19T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-reveals-expansion-plans-for-its-germany-facility-190213/ 2013-02-19T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/grovepoint-acquires-majority-stake-in-algatechnologies-190213/ 2013-02-19T06:22:00+00:00 https://www.pharmaceutical-business-review.com/news/hokutou-holdings-to-introduce-new-calcium-vitamin-d-supplement-190213/ 2013-02-19T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/vitamin-shoppe-closes-purchase-of-super-supplements-for-50m-190213/ 2013-02-19T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-sanofi-lixisenatide-nda-for-review-200213/ 2013-02-20T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/dsm-and-chemtrix-sign-collaboration-agreement-in-continuous-flow-chemistry-200213/ 2013-02-20T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/neuroindx-introduces-new-cell-and-tissue-acquisition-instrument-200213/ 2013-02-20T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/galectin-therapeutics-dr-geert-jan-boons-laboratory-partner-for-drug-discovery-program-200213/ 2013-02-20T03:04:00+00:00 https://www.pharmaceutical-business-review.com/news/imprimis-completes-clinical-trials-for-topical-analgesic-cream-impracor-200213/ 2013-02-20T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/spaulding-completes-fih-study-using-12-bed-fih-high-visibility-unit-200213/ 2013-02-20T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/nymox-releases-immunogenicity-results-for-nx-1207-bph-program-200213/ 2013-02-20T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-bayer-initiates-eylea-injection-phase-3-trial-200213/ 2013-02-20T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/galderma-wins-fda-approval-for-epiduo-gel-for-treating-acne-in-pediatric-patients-200213/ 2013-02-20T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/sov-wins-fda-orphan-drug-designation-for-oral-testosterone-replacement-therapy-210213/ 2013-02-21T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/dsi-renal-buys-new-smyrna-beach-artificial-kidney-center-210213/ 2013-02-21T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/cedars-sinai-medical-center-licenses-neuralstem-cns-devices-210213/ 2013-02-21T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/quest-diagnostics-to-offer-nateras-new-non-invasive-prenatal-test-210213/ 2013-02-21T03:27:00+00:00 https://www.pharmaceutical-business-review.com/news/sct-signs-joint-venture-agreement-with-reneu-nexgen-210213/ 2013-02-21T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/samsung-merck-sign-biosimilar-development-commercialization-agreement-210213/ 2013-02-21T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/agilent-unveils-sureselect-strand-specific-rna-library-preparation-kit-210213/ 2013-02-21T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/relypsa-completes-first-patient-enrollment-in-oral-hyperkalemia-drug-trial-210213/ 2013-02-21T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/telstar-adds-new-consulting-deployment-services-line-for-qbd-220213/ 2013-02-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-takes-over-us-rights-to-eisai-targretin-230213/ 2013-02-21T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/japan-approves-helicobacter-pylori-gastritis-as-extra-indication-for-helicobacter-pylori-eradication-220213/ 2013-02-22T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/cumberland-sandor-sign-caldolor-injection-commercialization-deal-in-india-220213/ 2013-02-22T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/genspera-treats-first-patient-in-g-202-phase-ii-hepatocellular-carcinoma-trial-220213/ 2013-02-22T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-aplastic-anemia-therapy-wins-fda-orphan-drug-status-220213/ 2013-02-22T03:14:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-to-develop-companion-diagnostic-test-for-investigational-leukemia-therapy-220213/ 2013-02-22T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/capsugel-opens-dosage-form-solutions-business-unit-220213/ 2013-02-22T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/basf-bend-research-partner-for-solubility-and-bioavailability-of-poorly-soluble-drugs-220213/ 2013-02-22T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/lupin-to-commence-shipment-of-suprax-oral-suspension-220213/ 2013-02-22T06:26:00+00:00 https://www.pharmaceutical-business-review.com/news/colorado-university-orphan-technologies-to-develop-new-treatment-for-homocystinuria-220213/ 2013-02-22T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/ehealth-client-outlook-announce-availability-of-image-viewing-platform-250213/ 2013-02-24T19:39:00+00:00 https://www.pharmaceutical-business-review.com/news/genesis-to-distribute-gvk-informatics-database-products-and-services-in-taiwan-250213/ 2013-02-24T23:25:00+00:00 https://www.pharmaceutical-business-review.com/news/immune-begins-phase-ii-study-of-ulcerative-colitis-drug-250213/ 2013-02-24T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/igy-immune-introduces-sports-nutrition-supplement-in-north-america-250213/ 2013-02-25T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/bosch-healthcare-greatcall-join-hands-to-develop-new-line-of-mobile-health-solutions-250213/ 2013-02-25T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aetna-launches-new-business-unit-brand-under-health-and-technology-services-250213/ 2013-02-25T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/wcct-global-launches-recruitment-management-tool-for-clinical-studies-250213/ 2013-02-25T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/mmodal-intermountain-healthcare-partner-to-develop-mobile-order-entry-app-250213/ 2013-02-25T02:35:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-confometrx-sign-drug-discovery-research-deal-250213/ 2013-02-25T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-to-resume-atorvastatin-production-for-us-marketplace-250213/ 2013-02-25T06:58:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-inks-deal-with-spirogen-to-evaluate-novel-anti-cancer-drug-conjugate-250213/ 2013-02-25T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-wins-fda-approval-for-metastatic-breast-cancer-drug-260213/ 2013-02-25T23:33:00+00:00 https://www.pharmaceutical-business-review.com/news/sihuan-pharma-to-commence-type-ii-diabetes-drug-trial-260213/ 2013-02-25T23:38:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-pharmaceuticals-launches-fenofibrate-capsules-260213/ 2013-02-26T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/viropro-oncobiologics-enter-into-biosimilar-collaboration-agreement-260213/ 2013-02-26T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ignyta-collaborates-with-leiden-university-medical-center-for-rheumatoid-arthritis-research-260213/ 2013-02-26T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/patientslikeme-receives-grant-to-create-open-participation-research-platform-260213/ 2013-02-26T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/agilent-technologies-collaborates-with-florida-university-on-designer-drugs-identification-260213/ 2013-02-26T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/olaax-recalls-natural-herb-supplement-for-weight-loss-260213/ 2013-02-26T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/top-secret-nutrition-launches-new-nutritional-supplement-270213/ 2013-02-26T22:09:00+00:00 https://www.pharmaceutical-business-review.com/news/vitamin-shoppe-q4-net-sales-up-by-192-270213/ 2013-02-26T22:13:00+00:00 https://www.pharmaceutical-business-review.com/news/vitalize-labs-launches-vitamin-infused-orange-energy-shot-270213/ 2013-02-26T22:17:00+00:00 https://www.pharmaceutical-business-review.com/news/adynxx-doses-first-patient-in-investigational-ayx1-phase-2-study-270213/ 2013-02-26T23:24:00+00:00 https://www.pharmaceutical-business-review.com/news/glide-pharma-completes-214m-fundraising-260213/ 2013-02-26T23:34:00+00:00 https://www.pharmaceutical-business-review.com/news/iof-fonterra-establish-bone-health-research-grant-270213/ 2013-02-27T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/bone-therapeutics-to-build-new-manufacturing-facility-in-belgium-270213/ 2013-02-27T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/qualicaps-to-invest-26m-for-whitsett-facility-expansion-270213/ 2013-02-27T03:54:00+00:00 https://www.pharmaceutical-business-review.com/news/profectus-althea-enter-into-manufacturing-deal-for-plasmid-dna-production-270213/ 2013-02-27T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/amarin-submits-vascepa-capsule-snda-to-fda-270213/ 2013-02-27T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-shionogis-osphena-tablets-to-treat-dyspareunia-270213/ 2013-02-27T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/avaxia-treats-first-patient-in-ulcerative-colitis-drug-study-270213/ 2013-02-27T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-therapeutics-presents-paz320-drug-positive-phase-ll-results-280213/ 2013-02-27T23:35:00+00:00 https://www.pharmaceutical-business-review.com/news/jazz-concert-pharma-sign-license-deal-for-narcolepsy-drug-development-280213/ 2013-02-27T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/280213fda-accepts-antares-nda-for-otrexup/ 2013-02-28T00:22:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-recalls-five-different-injections-280213/ 2013-02-28T03:06:00+00:00 https://www.pharmaceutical-business-review.com/news/rbcc-to-develop-sustained-release-drug-delivery-platform-280213/ 2013-02-28T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/west-pharmaceutical-launches-intradermal-adapter-for-disposable-syringes-280213/ 2013-02-28T03:14:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-submits-fda-approval-application-for-feiba-nf-drug-280213/ 2013-02-28T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/crystal-pharmatech-particle-sciences-partner-for-drug-solubility-solution-280213/ 2013-02-28T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-licenses-global-rights-to-tozadenant-280213/ 2013-02-28T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/arizona-ramsell-to-provide-medications-for-eligible-hivaids-patients-280213/ 2013-02-28T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/ibm-launches-new-data-system-for-analytics-to-address-physician-concerns-010313/ 2013-02-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aciex-portola-sign-research-deal-for-ophthalmic-drugs-010313/ 2013-02-28T23:08:00+00:00 https://www.pharmaceutical-business-review.com/news/fosun-atrium-enter-into-distribution-jv-in-china-010313/ 2013-02-28T23:11:00+00:00 https://www.pharmaceutical-business-review.com/news/ag-mednet-launches-cloud-storage-solution-for-clinical-trial-data-010313/ 2013-03-01T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/cenduit-to-expand-its-offices-in-us-switzerland-010313/ 2013-03-01T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/dezima-pharma-secures-186m-for-cetp-inhibitor-development-010313/ 2013-03-01T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/romaco-to-exhibit-packaging-technologies-at-pharmintech-exhibition-in-italy-010313/ 2013-03-01T03:34:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmatek-reveals-facility-expansion-plans-010313/ 2013-03-01T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/biocrates-life-sciences-to-launch-metabolomics-based-research-kit-010313/ 2013-03-01T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/nanoviricides-begins-its-cgmp-clinical-drug-facility-renovation-010313/ 2013-03-01T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/arrowhead-wins-noa-for-dpc-sirna-delivery-system-patent-application-040313/ 2013-03-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/citiustech-launches-new-saas-based-platform-for-healthcare-business-intelligence-040313/ 2013-03-03T23:28:00+00:00 https://www.pharmaceutical-business-review.com/news/liaison-healthcare-launches-cloud-based-customer-records-solution-for-pharma-industry-040313/ 2013-03-03T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/mmodal-claro-group-partner-to-help-acute-care-hospitals-to-improve-clinical-quality-040313/ 2013-03-03T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/kala-pharmaceuticals-raises-115m-in-series-a-financing-round-040313/ 2013-03-04T00:17:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-hamilton-launch-dna-sample-enrichment-platform-040313/ 2013-03-04T00:21:00+00:00 https://www.pharmaceutical-business-review.com/news/trilink-to-develop-ngs-rna-sample-preparation-approach-040313/ 2013-03-04T02:02:00+00:00 https://www.pharmaceutical-business-review.com/news/rxmedic-signs-partnership-agreement-with-rx-systems-040313/ 2013-03-04T05:18:00+00:00 https://www.pharmaceutical-business-review.com/news/steribeam-systems-introduces-pulsed-uv-sterilization-tunnels-040313/ 2013-03-04T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/swallow-solutions-completes-series-a-funding-040313/ 2013-03-04T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/spring-bank-pharma-raises-105m-in-series-a-financing-040313/ 2013-03-04T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/cytrx-completes-patient-enrollment-in-tamibarotene-phase-2b-study-050313/ 2013-03-05T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/vernalis-receives-25m-final-payment-from-genentech-050313/ 2013-03-05T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/psioxus-completes-patient-enrollment-in-mt-102-drug-phase-ii-study-050313/ 2013-03-05T00:35:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-biogen-idec-bla-for-hemophilia-b-therapy-050313/ 2013-03-05T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/mitosynergy-to-launch-its-supplement-at-natural-products-expo-west-050313/ 2013-03-05T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/sgi-dna-and-idt-expand-collaboration-for-synthetic-dna-products-050313/ 2013-03-05T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-renews-distribution-deal-with-yusen-logistics-050313/ 2013-03-05T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/taiho-seeks-japanese-approval-for-antitumor-agent-tas-102-050313/ 2013-03-05T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/pra-buys-clinstar-for-undisclosed-sum-050313/ 2013-03-05T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/cedarburg-hausers-denver-manufacturing-facility-gains-dea-registration-050313/ 2013-03-05T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-breaks-ground-on-new-manufacturing-plant-in-saudi-arabia-080313/ 2013-03-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/marinomed-biotechnologie-antiviral-nasal-spray-gets-canadian-approval-060313/ 2013-03-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/buy-prescopodene-launches-new-supplement-for-weight-loss-060313/ 2013-03-05T21:59:00+00:00 https://www.pharmaceutical-business-review.com/news/ocean-pharma-launches-stage-2-chronic-pain-otc-medication-060313/ 2013-03-05T23:57:00+00:00 https://www.pharmaceutical-business-review.com/news/riboxx-pharma-collaborates-with-cnbg-to-evaluate-potential-of-riboxxim-tlr3-agonist-060313/ 2013-03-06T00:07:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-presage-enter-into-strategic-research-collaboration-060313/ 2013-03-06T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/safc-to-expand-manufacturing-facility-in-scotland-060313/ 2013-03-06T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/saladax-obtains-224m-strategic-equity-investment-from-shanghai-fosun-pharmaceutical-060313/ 2013-03-06T03:34:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-labs-launches-generic-zometa-in-us-060313/ 2013-03-06T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/array-biopharma-global-blood-therapeutics-form-drug-discovery-collaboration-060313/ 2013-03-06T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/lycored-unveils-new-supplement-for-bone-health-060313/ 2013-03-06T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/glide-pharma-appoints-new-ceo-060313/ 2013-03-06T23:32:00+00:00 https://www.pharmaceutical-business-review.com/news/polypid-mis-implants-to-provide-drug-delivery-product-for-dental-applications-070313/ 2013-03-06T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-amag-snda-for-feraheme-label-expansion-070313/ 2013-03-07T00:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-iroko-lower-dose-submicron-diclofenac-nda-for-review-070313/ 2013-03-07T02:21:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvo-reports-fda-response-to-pennsaid-2-nda-070313/ 2013-03-07T02:43:00+00:00 https://www.pharmaceutical-business-review.com/news/particle-sciences-join-forces-with-netzsch-premier-technologies-070313/ 2013-03-07T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/dsm-inks-master-supply-agreement-with-eisai-070313/ 2013-03-07T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/miragen-university-of-glasgow-sign-licensing-agreement-for-microrna-145-070313/ 2013-03-07T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/ajinomoto-wins-top-tier-pharma-licensee-for-corynex-070313/ 2013-03-07T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/retrosense-wins-noa-for-vision-restoration-approaches-patent-application-070313/ 2013-03-07T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/dksh-extends-partnership-with-advance-pharma-in-malaysia-070313/ 2013-03-07T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-biolamina-partner-to-develop-new-cell-culture-systems-070313/ 2013-03-07T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-submits-ibd-disease-drug-maa-to-ema-080313/ 2013-03-08T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/proteonic-oet-extend-partnership-for-recombinant-protein-production-services-080313/ 2013-03-08T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/kings-college-london-wellcome-trust-advent-venture-set-up-new-biotech-company-080313/ 2013-03-08T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/ashland-reveals-expansion-plans-for-its-delaware-rd-facility-080313/ 2013-03-08T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/heel-launches-new-cold-remedy-080313/ 2013-03-08T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/biognosys-develops-mrm-assay-panel-for-toxicological-assessment-080313/ 2013-03-08T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/cellectis-stemgent-to-provide-genome-engineered-ips-cells-080313/ 2013-03-08T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/baycare-health-baystate-health-choose-intersystems-healthshare-as-informatics-platform-080313/ 2013-03-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/moberg-discontinues-actinic-keratosis-drug-development-110313/ 2013-03-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aeterna-zentaris-to-discontinue-phase-3-multiple-myeloma-study-of-perifosine-110813/ 2013-03-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/grifols-cadence-sign-manufacturing-supply-agreement-for-ofirmev-injection-120313/ 2013-03-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/avanir-signs-research-deal-to-screen-pba-symptom-in-veterans-with-tbi-120313/ 2013-03-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-hakko-kirin-to-construct-injectables-plant-in-japan-110313/ 2013-03-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-reveals-data-from-phase-4-terisa-study-of-angina-drug-110313/ 2013-03-11T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-ucb-introduce-rheumatoid-arthritis-therapy-in-japan-110313/ 2013-03-11T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/galectin-to-start-phase-1-clinical-study-of-fatty-liver-disease-drug-110313/ 2013-03-11T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/aod-software-launches-answers-pharmacy-interface-with-qs1-110313/ 2013-03-11T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/active-biotech-teva-complete-first-patient-enrollment-in-rrms-drug-phase-iii-study-110313/ 2013-03-11T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/adma-biologics-initiates-phase-iii-study-of-pidd-drug-110313/ 2013-03-11T03:26:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/indian-state-government-announces-new-pharmaceutical-policy-110313/ 2013-03-11T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/vaccine-world-summit-india-2013-honors-collaboration-for-malaria-vaccine-dvelopment-110313/ 2013-03-11T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-discontinues-development-of-filibuvir-drug-110313/ 2013-03-11T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/catalent-to-expand-softgel-technologies-clinical-supply-solutions-businesses-in-china-120313/ 2013-03-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/epharmasolutions-upgrades-ctp-etmf-for-cros-120313/ 2013-03-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/neurovive-takes-over-cyclophilin-inhibitors-technology-platform-assets-from-biotica-120313/ 2013-03-11T19:57:00+00:00 https://www.pharmaceutical-business-review.com/news/target-health-lifeonkey-get-bird-foundation-award-120313/ 2013-03-11T20:04:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-ambit-to-terminate-joint-development-deal-of-flt3-kinase-inhibitors-120313/ 2013-03-12T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/clinigen-theravance-sign-vibativ-commercialization-deal-110313/ 2013-03-12T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-selects-cancer-genetics-for-clinical-trial-services-in-chronic-lymphocytic-leukemia-120313/ 2013-03-12T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/ziopharm-initiates-phase-2-breast-cancer-study-of-ad-rts-il-12-palifosfamide-120313/ 2013-03-12T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/oceans-omega-dsm-nutritional-sign-otec-emulsion-ingredient-supply-contract-120313/ 2013-03-12T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/galderma-launches-pliaglis-topical-local-anesthetic-cream-in-us-120312/ 2013-03-12T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/activartis-cancer-immune-therapy-wins-european-orphan-drug-designation-110313/ 2013-03-12T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/green-plant-recalls-its-otc-dietary-supplement-night-bullet-120313/ 2013-03-12T06:43:00+00:00 https://www.pharmaceutical-business-review.com/news/tris-pharma-achieves-first-milestone-under-collaboration-with-vernalis-120313/ 2013-03-12T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-introduces-uhplc-liquid-junction-kit-120313/ 2013-03-12T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-opens-innovation-center-in-london-130313/ 2013-03-12T23:27:00+00:00 https://www.pharmaceutical-business-review.com/news/hokutou-to-launch-new-supplement-for-female-sexual-dysfunction-120313/ 2013-03-12T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-millipore-contract-research-laboratory-obtains-clia-certification-130313/ 2013-03-13T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/labceutics-asuragen-to-jointly-conduct-pan-european-study-on-cml-130313/ 2013-03-13T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/neuland-labs-mitsubishi-chemical-healthcare-unit-apic-forge-manufacturing-collaboration-130313/ 2013-03-13T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/nw-bio-to-expand-cross-border-supply-of-brain-cancer-product-dcvax-l-130313/ 2013-03-13T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/siga-delivers-first-courses-of-smallpox-antiviral-drug-arestvyr-to-us-130312/ 2013-03-13T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/sdhft-commences-construction-of-new-pharma-manufacturing-unit-in-england-200313/ 2013-03-13T02:49:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-shut-sirtris-pharmas-cambridge-office-130313/ 2013-03-13T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-seeks-fda-approval-to-market-hemophilia-a-therapy-130313/ 2013-03-13T06:27:00+00:00 https://www.pharmaceutical-business-review.com/news/neurometrix-handok-sign-nc-stat-dpncheck-distribution-deal-in-republic-of-korea-130313/ 2013-03-13T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/chimerix-cmx001-wins-fda-fast-track-designation-130313/ 2013-03-13T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/synta-pharma-names-new-president-of-rd-140313/ 2013-03-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/scripps-research-institute-takeda-expand-research-collaboration-140313/ 2013-03-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/meda-pharma-allergic-rhinitis-drug-dymista-gets-uk-mhra-approval-140313/ 2013-03-13T22:50:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-luminex-collaborate-to-develop-companion-diagnostic-device-140313/ 2013-03-14T00:10:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-neos-therapeutics-adhd-drug-nda-for-review-140313/ 2013-03-14T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/receptos-signs-orphan-disease-drug-development-license-deal-with-abbvie-140313/ 2013-03-14T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/lithera-treats-first-patient-with-lipo-202-in-reset-trial-140313/ 2013-03-14T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/evogen-focus-diagnostics-sign-licensing-agreement-for-hybeacons-pcr-probe-technology-140313/ 2013-03-14T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/navidea-biopharma-gets-fda-nod-for-lymphoseek-injection-140313/ 2013-03-14T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/immbio-gets-biomedical-catalyst-support-to-develop-pneumococcal-vaccine-pnubiovax-140313/ 2013-03-14T04:09:00+00:00 https://www.pharmaceutical-business-review.com/news/cardium-kids-vitarocks-vitamins-line-to-hit-select-target-shelves-140313/ 2013-03-14T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/n30-pharmaceuticals-begins-patient-treatment-in-phase-1b2a-cystic-fibrosis-study-140313/ 2013-03-14T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/presidio-boehringer-to-commence-phase-iia-direct-acting-antiviral-combination-treatment-trial-140313/ 2013-03-14T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/sirona-wins-european-patent-for-new-carbohydrate-based-compound-family-140313/ 2013-03-14T06:27:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-opts-for-elseviers-drug-information-technologies-150313/ 2013-03-14T19:41:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-india-sign-deal-to-support-rd-innovation-projects-150313/ 2013-03-14T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/ligand-spectrum-sign-captisol-enabled-melphalan-licensing-supply-deal-150313/ 2013-03-15T00:01:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/sistemic-pct-collaborate-to-study-sistemqc-stem-cell-characterization-technology-150313/ 2013-03-15T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/icu-medical-upgrades-automated-sterile-compounding-system-diana-150313/ 2013-03-15T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-par-pharma-fluvoxamine-maleate-er-capsules-anda-150313/ 2013-03-15T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-buys-swedish-biotechnology-company-premacure-150313/ 2013-03-15T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/sonoco-introduces-new-controlled-room-temperature-design-qualified-shippers-150313/ 2013-03-15T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/cryo-cell-affiliate-saneron-gets-new-patent-to-umbilical-cord-blood-processing-180313/ 2013-03-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/thrombogenics-jetrea-wins-approval-for-vitreomacular-traction-treatment-in-europe-180313/ 2013-03-18T00:05:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-hyglos-sign-licensing-agreement-for-endotoxin-detection-patents-180313/ 2013-03-18T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/ophthalix-concludes-patient-enrollment-in-dry-eye-syndrome-drug-phase-iii-study-180313/ 2013-03-18T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/genetex-to-launch-new-antibodies-to-study-dna-repair-180313/ 2013-03-18T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/topokine-university-of-bristol-partner-to-produce-fat-reducing-medications-180313/ 2013-03-18T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/sunshine-looking-for-cmos-for-breast-cancer-drug-adva-27a-manufacturing-180313/ 2013-03-18T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/diffusion-completes-enrolling-brain-cancer-patients-in-tsc-phase-ii-trial-180313/ 2013-03-18T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/us-hcg-injections-introduces-lipo-7-for-weight-loss-180313/ 2013-03-18T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/chromotek-bayer-sign-license-agreement-for-high-content-drug-profiling-180313/ 2013-03-18T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/transtech-alzheimers-disease-therapy-wins-fda-fast-track-status-190313/ 2013-03-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/finesse-releases-trubio-dv-45-bioreactor-control-software-190313/ 2013-03-18T18:31:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmamar-selects-medidata-clinical-cloud-platform-for-clinical-trials-190313/ 2013-03-18T19:04:00+00:00 https://www.pharmaceutical-business-review.com/news/medrio-offers-free-edc-software-to-university-researchers-190313/ 2013-03-18T19:50:00+00:00 https://www.pharmaceutical-business-review.com/news/raysearch-unveils-new-version-of-its-raystation-treatment-planning-system-190313/ 2013-03-18T20:38:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-protalix-type-i-gaucher-disease-drug-uplyso-gets-brazilian-approval-190313/ 2013-03-18T23:27:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-reports-positive-data-from-phase-iii-study-of-cialis-190313/ 2013-03-19T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-gets-fda-approval-for-generic-xopenex-inhalation-solution-190313/ 2013-03-19T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/proteologics-gsk-extend-research-collaboration-190313/ 2013-03-19T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-to-set-up-rd-center-in-gaithersburg-maryland-190313/ 2013-03-19T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/musclepharm-launches-new-line-of-supplements-for-women-190313/ 2013-03-19T04:16:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-precedex-injection-wins-six-months-pediatric-exclusivity-in-us-190313/ 2013-03-19T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/amerisource-enters-into-long-term-strategic-partnership-with-walgreens-alliance-boots-200313/ 2013-03-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/quidel-life-technologies-receive-us-fda-approval-for-clostridium-difficile-assay-200313/ 2013-03-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/galena-acquires-us-rights-to-orexo-abstral-sublingual-tablets-200313/ 2013-03-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/geneinsight-ingenuity-to-collaborate-on-integration-and-reporting-workflow-solution-200313/ 2013-03-19T21:45:00+00:00 https://www.pharmaceutical-business-review.com/news/canopy-partners-chooses-mmodal-catalyst-for-radiology-200313/ 2013-03-19T22:35:00+00:00 https://www.pharmaceutical-business-review.com/news/nps-pharma-regains-teduglutide-pth-1-84-worldwide-development-rights-from-takeda-200313/ 2013-03-19T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/certara-inks-partnership-agreement-with-chemaxon-200313/ 2013-03-19T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/addex-wins-1m-michael-j-fox-foundation-grant-for-parkinsons-disease-research-200313/ 2013-03-19T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/xceleron-partners-with-jcl-bioassay-200313/ 2013-03-20T00:20:00+00:00 https://www.pharmaceutical-business-review.com/news/rhema-takes-over-harmony-concepts-200313/ 2013-03-20T00:21:00+00:00 https://www.pharmaceutical-business-review.com/news/omega-nutrition-introduces-new-vegan-protein-supplement-200313/ 2013-03-20T00:37:00+00:00 https://www.pharmaceutical-business-review.com/news/lanxess-plans-chemicals-projects-in-gulf-cooperation-council-200313/ 2013-03-20T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/dksh-expands-contract-services-partnership-with-bayer-200313/ 2013-03-20T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/nw-bio-bags-us-patent-to-manufacture-human-dentric-cells-200313/ 2013-03-20T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/trimel-partners-with-european-firm-to-develop-respiratory-therapies-200313/ 2013-03-20T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/stevanato-expands-mexican-manufacturing-facility-210313/ 2013-03-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alder-announces-dosing-of-first-patients-in-phase-2-study-of-ald403-210313/ 2013-03-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-new-patent-for-oxigene-benzosuberene-based-compounds-210313/ 2013-03-20T23:53:00+00:00 https://www.pharmaceutical-business-review.com/news/bosch-launches-new-vial-filling-closing-machine-210313/ 2013-03-21T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-commences-shipment-of-generic-mucinex-600mg-210313/ 2013-03-21T02:35:00+00:00 https://www.pharmaceutical-business-review.com/news/nice-turns-down-novartis-breast-cancer-drug-210313/ 2013-03-21T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fibrocell-ucla-study-on-human-skin-cells-provides-positive-results-210313/ 2013-03-21T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/stellar-submits-subunit-klh-biologics-master-file-to-fda-210313/ 2013-03-21T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/dart-therapeutics-develops-drug-candidate-for-duchenne-muscular-dystrophy-210313/ 2013-03-21T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/greenwood-genetic-cartagenia-sign-licensing-agreement-for-clinical-data-analysis-solutions-220313/ 2013-03-21T22:00:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-launches-new-ecuador-subsidiary-to-expand-business-in-latin-america-220313/ 2013-03-21T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/premier-pharmacy-depoys-tcgrx-complete-shortcyclerx-workflow-solution-220313/ 2013-03-21T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/new-england-biolabs-opens-new-singapore-subsidiary-220313/ 2013-03-22T00:33:00+00:00 https://www.pharmaceutical-business-review.com/news/zimmer-introduces-new-injectable-pain-relief-gel-to-treat-knee-arthritis-220313/ 2013-03-22T00:43:00+00:00 https://www.pharmaceutical-business-review.com/news/tokyo-institute-astellas-form-joint-research-deal-against-neglected-tropical-diseases/ 2013-03-22T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/benitec-selects-new-site-for-phase-iii-hepatitis-c-trial-of-tt-034-220313/ 2013-03-22T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/nordion-dr-reddys-laboratories-settle-claims-220313/ 2013-03-22T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/deinove-to-establish-new-subsidiary-for-antibiotics-program-220313/ 2013-03-22T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-receives-sanction-from-jpma-for-alinamin-f5-injection-220313/ 2013-03-22T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-recommends-approval-of-titans-probuphine-220313/ 2013-03-22T11:15:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-novartis-anti-bacterial-inhaler-for-certain-cystic-fibrosis-patients-250313/ 2013-03-25T00:08:00+00:00 https://www.pharmaceutical-business-review.com/news/pall-launches-new-bioreactor-system-for-improved-cell-culture-performance-250313/ 2013-03-25T01:16:00+00:00 https://www.pharmaceutical-business-review.com/news/chinese-sfda-issues-gmp-certification-to-simcere-influenza-vaccine-production-facility-250313/ 2013-03-25T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-multiple-sclerosis-drug-receives-positive-chmp-opinion-in-europe-250313/ 2013-03-25T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/cirm-funds-cellular-dynamics-coriell-institute-to-manufacture-stem-cells-250313/ 2013-03-25T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/bellwyck-packaging-shifts-premium-packaging-division-to-larger-facility-250313/ 2013-03-25T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/bluebird-celgene-to-advance-gene-therapy-in-oncology-250313/ 2013-03-25T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/h3-biomedicine-bgi-join-forces-for-cancer-genomic-sequencing-data-250313/ 2013-03-25T08:03:00+00:00 https://www.pharmaceutical-business-review.com/news/biocryst-begins-phase-1-bcx4161-study-for-hereditary-angioedema-treatment-260313/ 2013-03-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-eli-lilly-submit-nda-for-investigational-type-2-diabetes-therapy-in-us-260313/ 2013-03-25T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/bio-rep-unveils-new-immune-supplement-product-line-260313/ 2013-03-26T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/japan-ministry-of-health-labour-and-welfare-approves-functional-dyspepsia-medication-260313/ 2013-03-26T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-transgene-partner-to-develop-new-platform-to-produce-immunotherapy-products-260313/ 2013-03-26T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/poms-mes-helps-rovisys-expand-life-science-capabilities-260313/ 2013-03-26T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/trius-reports-positive-data-from-establish-2-phase-3-study-of-tedizolid-260313/ 2013-03-26T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-introduces-lablink-xl-cloud-communicator-260313/ 2013-03-26T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/biotime-lifemap-sciences-sign-data-mining-collaboration-agreement-260313/ 2013-03-26T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/auxilium-reports-positive-data-from-phase-iia-frozen-shoulder-syndrome-study-260313/ 2013-03-26T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/argen-x-advances-argx-112-into-preclinical-development-260313/ 2013-03-26T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/island-abbey-foods-launches-new-honibe-honey-vitamins-product-line-260313/ 2013-03-26T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/creative-edge-enters-into-medical-marijuana-sector-through-hemp-plex-chia-plex-260313/ 2013-03-26T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-wins-positive-chmp-opinion-for-stribild-drug-260313/ 2013-03-26T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/gore-pharmbio-launches-new-gaskets-for-pharmaceutical-applications-260313/ 2013-03-26T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-astrazeneca-reach-settlement-agreement-for-crestor-generic-version-260313/ 2013-03-26T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/vitamin-shoppe-opens-first-international-franchise-in-panama-city-270313/ 2013-03-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-otsuka-collaborate-to-develop-lu-ae58054-270313/ 2013-03-27T00:03:00+00:00 https://www.pharmaceutical-business-review.com/news/dart-biovista-to-develop-new-drug-repositioning-candidates-for-dmd-270313/ 2013-03-27T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-texas-am-university-obtain-us-dhhs-clearance-for-new-influenza-vaccine-facility-270313/ 2013-03-27T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/eqalix-receives-grant-from-nanotechnology-institute-270313/ 2013-03-27T00:22:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-receives-pharmaroths-ndi-notification-for-sucanon-270313/ 2013-03-27T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/japanese-approval-of-arzerra-triggers-milestone-payment-to-genmab-270313/ 2013-03-27T03:01:00+00:00 https://www.pharmaceutical-business-review.com/news/biodelivery-arcion-sign-licensing-deal-for-topical-clonidine-gel-development-270313/ 2013-03-27T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/amic-gsg-join-forces-for-medical-isotopes-production-technologies-270313/ 2013-03-27T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aptalis-pharma-deploys-cegedims-mobile-crm-solutions-280313/ 2013-03-27T16:15:00+00:00 https://www.pharmaceutical-business-review.com/news/gentium-announces-commencement-of-phase-1-defibrotide-study-in-healthy-adults-280313/ 2013-03-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dalton-obtains-notice-of-award-form-nida-for-research-280313/ 2013-03-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/g-con-howorth-collaborate-for-gmp-therapeutics-manufacturing-solutions-280313/ 2013-03-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fhcrc-deploys-ekahaus-wi-fi-based-real-time-temperature-sensing-solution-280313/ 2013-03-27T19:20:00+00:00 https://www.pharmaceutical-business-review.com/news/genalyte-receives-ce-mark-for-its-maverick-detection-system-280313/ 2013-03-27T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-merck-bla-for-investigational-allergy-immunotherapy-tablet-280313/ 2013-03-28T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/medicyte-signs-licensing-deal-with-life-technologies-for-upcyte-cell-development-280313/ 2013-03-28T00:21:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-shionogis-marketing-authorisation-application-for-ospemifene-280313/ 2013-03-28T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-first-drug-for-launch-in-bd-simplist-line-of-prefilled-generic-injectables-280313/ 2013-03-28T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/breckenridge-to-market-generic-inderal-la-drug-280313/ 2013-03-28T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-eisai-gastroesophageal-reflux-disease-therapy-for-children-280313/ 2013-03-28T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/vetter-center-for-visual-inspection-and-logistics-clears-fda-gmp-inspection-280313/ 2013-03-28T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-biogen-capsule-for-multiple-sclerosis-280313/ 2013-03-28T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/sfda-approves-life-technologies-3500xl-dx-genetic-analyzer-280313/ 2013-03-28T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-conditional-marketing-authorization-for-pfizers-bosulif-290313/ 2013-03-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-submits-cell-culture-based-pandemic-influenza-vaccine-ndas-in-japan-010413/ 2013-03-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-university-of-birmingham-to-advance-lc-ms-techniques-for-life-science-applications-010413/ 2013-03-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-to-expand-manufacturing-operations-in-vietnam-010413/ 2013-03-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/clinigen-acquires-cardioxane-from-novartis-010413/ 2013-03-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/edison-pharmaceuticals-inks-deal-with-japans-dainippon-sumitomo-for-epi-743-epi-589-010413/ 2013-03-31T19:30:00+00:00 https://www.pharmaceutical-business-review.com/news/omegafort-nutriforce-introduce-omega-3-supplement-for-athletes-010413/ 2013-03-31T20:30:00+00:00 https://www.pharmaceutical-business-review.com/news/millennium-win-partner-to-make-personalized-therapies-available-to-cancer-patients-010413/ 2013-04-01T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-opens-office-of-orphan-disease-treatment-institute-010413/ 2013-04-01T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/trovagene-launches-hpv-assay-010413/ 2013-04-01T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/kinemed-renews-non-exclusive-research-agreement-with-pfizer-010413/ 2013-04-01T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-clears-teva-quartette-oral-contraceptive-nda-010413/ 2013-04-01T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-launches-zenatane-in-us-010413/ 2013-04-01T04:05:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-seeks-fda-approval-for-simeprevir-to-treat-genotype-1-chronic-hepatitis-c/ 2013-04-01T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-janssens-invokana-for-type-2-diabetes-010413/ 2013-04-01T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-integrates-dspp-and-dscp-odawara-plants-010413/ 2013-04-01T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/amerisourcebergen-to-sell-canadian-pharmaceutical-distribution-business-010413/ 2013-04-01T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/curevac-begins-cv9104-phase-2b-trial-in-prostate-cancer-patients-010413/ 2013-04-01T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/mission-pharmacal-introduces-flavored-oral-asthma-medicine-010413/ 2013-04-01T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/us-district-court-rules-astrazenecas-pulmicort-patent-invalid-020413/ 2013-04-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/finesse-introduces-smartparts-for-intelligent-universal-controllers-020413/ 2013-04-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-dod-funds-development-of-new-agent-to-prevent-multi-drug-resistant-skin-infections-020413/ 2013-04-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-receives-sanction-from-opma-for-alinamin-f5-injection-020413/ 2013-04-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ra-pharmaceuticals-merck-collaborate-to-develop-cyclomimetics-020413/ 2013-04-02T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/biomarin-submits-clinical-trial-application-with-mhra-for-batten-disease-drug-020413/ 2013-04-02T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/act-commences-higher-dosage-cohort-treatment-in-two-trials-for-macular-degeneration-020413/ 2013-04-02T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/sweden-clears-tengion-for-neo-kidney-augment-phase-1-trial-020413/ 2013-04-02T02:10:00+00:00 https://www.pharmaceutical-business-review.com/news/indian-apex-court-rejects-novartis-patent-plea-for-glivec-020413/ 2013-04-02T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/axelar-axl-003-demonstrates-efficacy-in-phase-ii-lung-cancer-study-020413/ 2013-04-02T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-next-pharmaceuticals-relora-020413/ 2013-04-02T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-seeks-mexican-marketing-approval-for-belviq-020413/ 2013-04-02T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-selects-labcorp-clinical-trials-for-global-central-laboratory-services-020413/ 2013-04-02T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-to-spend-extra-180m-to-expand-insulin-manufacturing-operations-in-indianapolis-030413/ 2013-04-03T00:21:00+00:00 https://www.pharmaceutical-business-review.com/news/weight-loss-pills-canada-opens-new-diet-supplement-site-030413/ 2013-04-03T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/arqule-regains-global-rights-to-akt-program-from-daiichi-030413/ 2013-04-03T02:31:00+00:00 https://www.pharmaceutical-business-review.com/news/nirogam-india-tier-one-national-partner-to-promote-ayurvedic-supplements-030413/ 2013-04-03T02:39:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-warns-on-adverse-effects-of-over-the-counter-allergy-medications-for-kids-030413/ 2013-04-03T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/cellular-dynamics-opens-new-facility-to-create-and-bank-ipscs-040413/ 2013-04-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-clears-new-manufacturing-facility-for-ruconest-inhibitor-040413/ 2013-04-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-recommends-changes-to-nicotine-medications-labeling-040413/ 2013-04-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bind-pfizer-collaborate-to-develop-multiple-accurins-040413/ 2013-04-04T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mylans-anda-for-acyclovir-ointment-040413/ 2013-04-04T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/hovione-signs-captisol-technology-co-promotion-agreement-with-ligand/ 2013-04-04T01:52:00+00:00 https://www.pharmaceutical-business-review.com/news/theravida-sk-chemicals-sign-licensing-deal-for-thvd-201-thvd-202-drug-development-040413/ 2013-04-04T02:11:00+00:00 https://www.pharmaceutical-business-review.com/news/rockwell-submits-injectable-active-vitamin-d-drug-manufacturing-data-to-fda-040413/ 2013-04-04T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/dispersinb-combination-wound-gel-spray-clears-primary-skin-irritation-tests-040413/ 2013-04-04T02:36:00+00:00 https://www.pharmaceutical-business-review.com/news/oramed-pharmaceuticals-wins-japanese-patent-for-oral-delivery-technology-040413/ 2013-04-04T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-daratumumab-wins-fda-fast-track-designation-040413/ 2013-04-04T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-announces-commencement-of-phase-iii-study-of-vasculitis-drug-040413/ 2013-04-04T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-market-four-strain-influenza-vaccine-in-germany-and-uk-040413/ 2013-04-04T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/frontage-extends-pain-medication-development-services-050413/ 2013-04-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/perceptive-informatics-launches-upgraded-impact-ctms-solution-050413/ 2013-04-05T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-ambrx-to-develop-new-antibody-drug-conjugates-for-oncology-050413/ 2013-04-05T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/aragen-innovent-partner-to-develop-manufacturing-cell-lines-for-biotherapeutic-050413/ 2013-04-05T00:54:00+00:00 https://www.pharmaceutical-business-review.com/news/covis-to-gain-us-rights-to-certain-sanofi-products-050413/ 2013-04-05T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/aastrom-begins-patient-enrollment-in-ixcell-dcm-trial-050413/ 2013-04-05T02:54:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-behring-privigen-wins-european-marketing-authorization-050413/ 2013-04-05T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/ag-mednet-biovisiq-collaborate-to-improve-clinical-trial-quality-across-asia-market-050413/ 2013-04-05T03:13:00+00:00 https://www.pharmaceutical-business-review.com/news/t2-biosystems-candida-diagnostic-test-wins-us-patent-050413/ 2013-04-05T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/promega-launches-geneprint10-system-for-human-cell-line-authentication-050413/ 2013-04-05T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/ajinomoto-completes-acquisition-of-althea-technologies-050413/ 2013-04-05T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/crown-bioscience-horizon-sign-two-year-drug-discovery-collaboration-agreement-050413/ 2013-04-05T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/life-technologies-introduces-oncomine-bioinformatics-solutions-for-cancer-researchers-080413/ 2013-04-07T18:15:00+00:00 https://www.pharmaceutical-business-review.com/news/icm-selects-ibm-supercomputer-for-biomedical-research-initiative-080413/ 2013-04-07T23:28:00+00:00 https://www.pharmaceutical-business-review.com/news/kowa-daiichi-to-terminate-livalo-olmetec-joint-marketing-partnership-in-japan-080413/ 2013-04-08T00:37:00+00:00 https://www.pharmaceutical-business-review.com/news/arena-begins-dosing-in-phase-1-trial-of-apd334-080413/ 2013-04-08T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/helix-begins-enrolment-for-third-dose-level-cohort-of-phase-iii-study-of-l-dos47-080413/ 2013-04-08T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-valeant-collaborate-for-generic-zovirax-ointment-080413/ 2013-04-08T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/neuralstem-wins-notice-of-allowance-for-new-patent-on-amyotrophic-lateral-sclerosis-treatment-methods-080413/ 2013-04-08T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-reports-top-line-results-from-oskira-1-ra-study-of-fostamatinib-080413/ 2013-04-08T05:18:00+00:00 https://www.pharmaceutical-business-review.com/news/kannalife-collaborates-with-advanced-neural-dynamics-iteramed-for-neuroprotectants-discovery-080413/ 2013-04-08T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/vaxinnate-awarded-us-grant-to-develop-recombinant-vaccine-for-dengue-080413/ 2013-04-08T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/novum-establishes-new-early-stage-clinical-facility-in-houston-090413/ 2013-04-08T08:06:00+00:00 https://www.pharmaceutical-business-review.com/news/tianyin-set-to-complete-construction-of-qionglai-facility-080413/ 2013-04-08T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/us-judge-rules-tevas-contraceptive-pill-available-over-the-counter-090413/ 2013-04-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/activaero-reports-results-of-phase-ii-trial-in-children-with-asthma-090413/ 2013-04-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-challenges-indian-courts-interim-order-100413/ 2013-04-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/molecular-response-introduces-new-platform-for-new-oncology-targets-090413/ 2013-04-08T21:24:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-astar-to-jointly-develop-new-medicines-for-emerging-markets-080413/ 2013-04-09T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/canbex-completes-fundraising-round-for-multiple-sclerosis-candidate-development-090413/ 2013-04-09T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/argentina-clears-genzyme-multiple-sclerosis-drug-090413/ 2013-04-09T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/innopharma-launches-cosyntropin-injection-025mgvial-in-us-090413/ 2013-04-09T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/biomed-announces-lease-expansion-with-rms-at-pacific-research-center-090413/ 2013-04-09T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/diet-doc-develops-new-7-keto-dhea-for-weight-loss-090413/ 2013-04-09T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/lassens-natural-foods-and-vitamins-sells-dr-garbers-natural-products-090413/ 2013-04-09T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-dysport-receives-marketing-authorization-in-canada-090413/ 2013-04-09T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-bristol-myers-to-conduct-phase-2-studies-of-vx-135-in-combination-with-daclatasvir-090413/ 2013-04-09T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/scpharmaceuticals-sensile-medical-to-develop-heart-failure-treatment-090413/ 2013-04-09T08:16:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-begins-spi-2012-phase-2-study-090413/ 2013-04-09T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/tissuegen-introduces-elute-biodegradable-drug-loaded-fiber-products-100413/ 2013-04-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bignutrition-to-add-additional-ingredient-to-acai-ultrazax-diet-supplement-100413/ 2013-04-10T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/menarini-to-pay-furiex-for-priligy-launch-in-france-100413/ 2013-04-10T00:41:00+00:00 https://www.pharmaceutical-business-review.com/news/quest-signs-licensing-deal-with-ucla-for-anti-psa-ige-technology-100413/ 2013-04-10T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-to-establish-rd-center-in-new-jersey-100413/ 2013-04-10T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/eddingpharm-to-acquire-tykerb-rights-from-glaxosmithkline-china-100413/ 2013-04-10T02:13:00+00:00 https://www.pharmaceutical-business-review.com/news/dana-farber-cancer-institute-to-support-brainstorms-phase-2-als-trial-100413/ 2013-04-10T02:55:00+00:00 https://www.pharmaceutical-business-review.com/news/nordic-naturals-introduces-new-softgel-for-cardiovascular-health-100413/ 2013-04-10T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/aeterna-ergomed-to-co-develop-endometrial-cancer-drug-110413/ 2013-04-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/shasun-pharmaceuticals-debiopharm-to-manufacture-huperzine-a-110413/ 2013-04-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-receives-breakthrough-therapy-designation-for-breast-cancer-drug-110413/ 2013-04-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nice-recommends-novartis-lucentis-for-nhs-use-110413/ 2013-04-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ge-healthcare-signs-new-manufacturing-facility-contract-in-brazil-110413/ 2013-04-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-canada-introduces-overactive-bladder-medication-110413/ 2013-04-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sunshine-hmec-study-reveals-adva-27a-non-toxicity-at-high-concentrations-110313/ 2013-04-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novalix-inventiva-join-forces-for-nuclear-receptors-110413/ 2013-04-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/shionogi-opts-for-qumas-compliancesp-for-quality-content-management-110413/ 2013-04-10T18:42:00+00:00 https://www.pharmaceutical-business-review.com/news/pw-informatics-develops-new-technology-for-risk-minimisation-of-drugs-110413/ 2013-04-10T20:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-duchesnayusas-diclegis-for-treatment-of-nvp-110413/ 2013-04-10T23:49:00+00:00 https://www.pharmaceutical-business-review.com/news/proteros-priaxon-collaborate-to-develop-lead-compounds-for-ppi-drug-targets-110413/ 2013-04-10T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-medicis-resolve-patent-litigations-120413/ 2013-04-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mobidiag-genewave-amplidiag-merge-to-develop-new-diagnostic-tests-for-infectious-diseases-120413/ 2013-04-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gvk-bio-university-of-dundee-sign-licensing-deal-for-online-sar-database-120413/ 2013-04-12T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/dksh-to-provide-commercial-distribution-services-to-pfizer-in-cambodia-120413/ 2013-04-12T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/iroko-phase-iii-studies-of-nsaid-pipeline-meet-primary-endpoints-120413/ 2013-04-12T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/alcon-launches-first-medicine-to-treat-vitreomacular-traction-in-uk-120413/ 2013-04-12T03:01:00+00:00 https://www.pharmaceutical-business-review.com/news/water-street-invests-in-pharmaceutical-services-company-120413/ 2013-04-12T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/singapore-opens-new-research-centre-for-asian-biological-discoveries-150413/ 2013-04-12T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/naturex-develops-new-dietary-supplement-concepts-120413/ 2013-04-12T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/rollprint-invests-in-new-pouch-production-facility-120413/ 2013-04-12T08:44:00+00:00 https://www.pharmaceutical-business-review.com/news/chattem-announces-availability-of-allegra-over-the-counter-in-us-120413/ 2013-04-12T08:49:00+00:00 https://www.pharmaceutical-business-review.com/news/alitair-to-sell-two-ion-exchange-resin-patents-120413/ 2013-04-12T08:51:00+00:00 https://www.pharmaceutical-business-review.com/news/oncogenex-to-begin-spruce-clinical-trial-to-evaluate-lung-cancer-agent-120413/ 2013-04-12T09:02:00+00:00 https://www.pharmaceutical-business-review.com/news/sorbent-begins-clp-1001-phase-2b-trial-in-heart-failure-patients-120413/ 2013-04-12T09:21:00+00:00 https://www.pharmaceutical-business-review.com/news/immune-design-scynexis-partner-for-cgmp-production-of-glucopyranosyl-lipid-a-150413/ 2013-04-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/life-technologies-launches-vector-nti-express-designer-150413/ 2013-04-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/actelion-pharmaceuticals-russia-installs-new-crm-solution-150413/ 2013-04-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/romaco-introduces-new-liquid-filling-machines-150413/ 2013-04-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/isatori-to-introduce-new-natural-weight-loss-supplement-in-us-150413/ 2013-04-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/puramed-bioscience-to-expand-retail-sales-efforts-of-otc-migrane-product-150413/ 2013-04-14T19:30:00+00:00 https://www.pharmaceutical-business-review.com/news/onepoint-patient-care-offers-medication-dispensing-services-to-new-hospice-partners-150413/ 2013-04-14T20:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-otsuka-tolvaptan-nda-for-priority-review-150413/ 2013-04-15T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sarepta-uwa-partner-to-develop-drugs-for-dmd-treatment-150413/ 2013-04-15T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/lupin-obtains-final-fda-marketing-approval-for-daysee-tablets-150413/ 2013-04-15T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/angany-genetics-to-commence-new-allergen-production-unit-in-france-150413/ 2013-04-15T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/atmi-disposable-lab-introduce-single-use-platform-for-fillfinish-operations-150413/ 2013-04-15T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/china-clears-synutras-new-drying-facility-in-france-160413/ 2013-04-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-ascletis-to-jointly-develop-investigational-hepatitis-c-drug-in-china-160413/ 2013-04-16T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/ares-life-sciences-to-acquire-us-firm-antigen-laboratories-160413/ 2013-04-16T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-alert-on-lack-of-sterility-assurance-of-apothecure-nuvision-drugs-160413/ 2013-04-16T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/cromos-opens-new-office-in-republic-of-georgia-160413/ 2013-04-16T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/neuralgene-to-initiate-animal-studies-evaluating-amyotrophic-lateral-sclerosisgene-therapy-160413/ 2013-04-16T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/sirtexmedical-completes-patient-recruitment-for-sirflox-study-160413/ 2013-04-16T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/corerx-plans-to-invest-2m-to-expand-manufacturing-capabilities-160413/ 2013-04-16T08:26:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-enrolls-last-patient-in-one-cohort-of-mm-121-phase-2-breast-cancer-study-160413/ 2013-04-16T08:35:00+00:00 https://www.pharmaceutical-business-review.com/news/santaris-bristol-myers-partner-to-develop-rna-targeted-medicines-160413/ 2013-04-16T08:42:00+00:00 https://www.pharmaceutical-business-review.com/news/covance-expands-singapore-central-laboratory-170413/ 2013-04-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/injex-pharma-receives-chinese-registration-for-needle-free-injection-system-170413/ 2013-04-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-complete-response-letter-to-allergans-nda-for-migraine-therapy-170413/ 2013-04-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-supreme-court-may-rule-against-human-gene-patents-170413/ 2013-04-17T00:38:00+00:00 https://www.pharmaceutical-business-review.com/news/n30-pharma-selects-greenphires-global-payment-technology-platforms-170413/ 2013-04-17T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/canada-funds-immunovaccine-respiratory-syncytial-virus-vaccine-development-170413/ 2013-04-17T03:43:00+00:00 https://www.pharmaceutical-business-review.com/news/pfenex-agila-biotech-to-develop-biosimilar-products-170413/ 2013-04-17T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-phase-iii-award-trials-of-type-2-diabetes-drug-meet-primary-efficacy-endpoints-170413/ 2013-04-17T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/taisho-to-launch-epadel-t-in-japan-170413/ 2013-04-17T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/biofire-seeks-fda-approval-for-filmarray-blood-culture-identification-test-170413/ 2013-04-17T08:14:00+00:00 https://www.pharmaceutical-business-review.com/news/clondalkin-deploys-new-booklet-label-machine-170413/ 2013-04-17T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/asmacure-commences-phase-12-trial-of-asm-024-dry-powder-for-inhalation-170413/ 2013-04-17T08:29:00+00:00 https://www.pharmaceutical-business-review.com/news/pharming-santarus-submit-biologics-license-application-for-ruconest-170413/ 2013-04-17T08:33:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-ranbaxy-sign-synergistic-collaboration-in-brazil-180413/ 2013-04-18T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/aeterna-transfers-cetrotide-manufacturing-license-to-merck-serono-180413/ 2013-04-18T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/entera-health-selects-stayinfronts-crm-solution-180413/ 2013-04-18T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-acquires-siemens-investigational-pet-tracers-for-alzheimers-research-180413/ 2013-04-18T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/cellectis-develops-vizucell-cell-lines-for-biomedical-research-cell-biology-180413/ 2013-04-18T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/myriad-raindance-collaborate-for-hereditary-cancer-panel-test-180413/ 2013-04-18T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-neuralstem-phase-ii-amytrophic-lateral-sclerosis-trial-180413/ 2013-04-18T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/xencor-licenses-xtend-protein-half-life-extension-technology-to-csl-180413/ 2013-04-18T08:33:00+00:00 https://www.pharmaceutical-business-review.com/news/qua-launches-new-fractional-electrodeionization-product-range-180413/ 2013-04-18T09:00:00+00:00 https://www.pharmaceutical-business-review.com/news/sk-biopharmaceuticals-sk-chemicals-sign-ykp10811-co-development-deal-190413/ 2013-04-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aastrom-treats-first-patients-in-ixcell-dcm-phase-2b-trial-190413/ 2013-04-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biotime-signs-licensing-deal-for-stroke-treatment-technology-190413/ 2013-04-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/suven-life-sciences-receives-four-product-patents-for-nces-190413/ 2013-04-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pieris-acheives-second-milestone-payment-under-anticalin-therapeutic-collaboration-with-daiichi-190413/ 2013-04-19T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/gerresheimer-begins-production-of-disposable-insulin-pen-components-190413/ 2013-04-19T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-opens-new-chinese-manufacturing-facility-190413/ 2013-04-19T01:55:00+00:00